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ABSTRACT
The U.S. health care system is considered costly and highly inefficient, devoting
substantial resources to the treatment of acute conditions in a hospital setting rather
than focusing on prevention and keeping patients out of the hospital. The poten-
tial for cost savings is large; in the U.S. more than $30 billion are spent each year
on hospitalizations deemed preventable, 31% of which is attributed to heart diseases
and 20% to diabetes. Motivated by this, our work focuses on developing central-
ized and distributed learning methods to predict future heart- or diabetes- related
hospitalizations based on patient Electronic Health Records (EHRs).
We explore a variety of supervised classification methods and we present a novel
likelihood ratio based method (K-LRT) that predicts hospitalizations and offers in-
terpretability by identifying the K most significant features that lead to a positive
prediction for each patient. Next, assuming that the positive class consists of multi-
ple clusters (hospitalized patients due to different reasons), while the negative class
is drawn from a single cluster (non-hospitalized patients healthy in every aspect), we
present an alternating optimization approach, which jointly discovers the clusters in
vi
the positive class and optimizes the classifiers that separate each positive cluster from
the negative samples. We establish the convergence of the method and characterize its
VC dimension. Last, we develop a decentralized cluster Primal-Dual Splitting (cPDS)
method for large-scale problems, that is computationally efficient and privacy-aware.
Such a distributed learning scheme is relevant for multi-institutional collaborations
or peer-to-peer applications, allowing the agents to collaborate, while keeping every
participant’s data private. cPDS is proved to have an improved convergence rate
compared to existing centralized and decentralized methods. We test all methods
on real EHR data from the Boston Medical Center and compare results in terms of
prediction accuracy and interpretability.
vii
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1Chapter 1
Introduction
1.1 Machine Learning in Healthcare
1.1.1 The Significance: An Underlying Motive
Healthcare has adapted to the recent advancements in machine learning and the
unprecedented explosion of data. Mainly economic, if not other quality-of-service
related, reasons play a key role in the transformation that healthcare is undergoing.
In 2006, health-care expenses represented 15.5% of the United States (U.S.) gross
domestic product (GDP) [Jiang et al., 2009], while in 2013, this percentage was in-
creased to 17.6% [Groves et al., 2013], that is nearly $600 billion more than what
was expected of a country with the U.S.’s size and wealth.1 The World Health Orga-
nization estimates that healthcare costs will grow to 20% of U.S.’s GDP (nearly $5
trillion) by 2021 [Adler and Hoagland, 2012], especially with civilization diseases (or
else called lifestyle diseases), like diabetes, coronary heart disease and obesity, grow-
ing. At the same time, machine learning (ML), whose aim is to develop algorithmic
systems that can learn from data, improve through experience and be used for pre-
dictions, provides the tools needed to address a variety of diagnostic and prognostic
medical problems.
1This estimate is based on McKinsey’s regression analysis of income and spending data from other
countries in the Organization of Economic Co-operation and Development. This measure estimates
how much a country is expected to spend on healthcare based on per capita GDP [Groves et al.,
2013].
21.1.2 Healthcare Big Data
Traditionally, healthcare data have been static, paper-based and used for record keep-
ing and information sharing. The digitalization of patients’ records started more than
two decades ago. Widespread adoption of electronic health records (EHRs) (else called
electronic medical records EMRs, or personal health records PHRs), has generated
massive data sets. 87% of US office-based physicians were using them by the end of
2015, up from 42% in 2008 [Office of the National Coordinator for Health Information
Technology, 2016]. EHRs have found diverse uses [Ludwick and Doucette, 2009], e.g.,
in assisting the quality management in hospitals [Takeda et al., 2003], in detecting
adverse drug reactions [Hannan, 1999], and in general primary care [Wang et al.,
2003]. These early application uses of EHRs merely scratch the surface of what may
be possible.
Healthcare data nowadays, are being collected and stored massively and cheaply
in data warehouses. They come from various sources and can be of different types:
insurance claims and cost data, research and development data developed over the
years and aggregated into medical databases by pharmaceutical companies, electronic
health records, genomic sequences, human genetics, population data, clinical trial
data, patients’ behavior data etc. Most recent forms include biometric sensor read-
ings, 3D imaging and more. EHRs form a rich set that might include demographics,
hospital admissions, the patient’s admitting, primary and secondary diagnoses, pro-
cedures, the physician’s name, the hospital’s name, nurse and doctor’s notes, treat-
ment reimbursement codes, discharge records, MRI (magnetic resonance imaging)
and other images, ECGs (electrocardiograms) etc. EHRs also contain quantitative
data (e.g., laboratory values, blood pressure measurements), qualitative data (e.g.,
text-based notes, demographic information) and transactional data (e.g., records of
drug deliveries) [Murdoch and Detsky, 2013].
3In 2001, D. Laney introduced “the three V” dimensions along which big data are
expanding [Laney, 2001]: volume, velocity and variety. In [Raghupathi and Raghu-
pathi, 2014], it is reported that the U.S. healthcare system data reached, in 2011, 150
exabytes and that at this rate of growth they will soon be on the order of zettabytes
or yottabytes. Two perhaps even greater challenges than volume, are the variety of
healthcare data, that come from diverse sources, all of which need to be utilized in
order to fully leverage the potential of analytics, and the velocity. Velocity refers to
the fact that healthcare data do not come only in static formats anymore. Nowadays
real-time measurements are available by regular monitoring, e.g., diabetic glucose
measurements, blood pressure readings, ECGs, data from operating room monitoring
or new data streams, such as heart rate measurements, from fitness trackers. Of-
tentimes, critical outcomes, such as life or death, depend on mining those real-time
streams. For example, in [Convertino et al., 2011] monitoring noninvasively measured
hemodynamic signals detects early indicators of blood volume loss and impending cir-
culatory failure in conscious, healthy humans who experience reduced central blood
volume. In [Jin et al., 2009] real-time electrocardiographic monitoring can predict the
cardiovascular disease, since heart rhythm irregularities cannot always be detected on
a standard resting ECG machine.
Since 2011, a fourth dimension has been added to the description of big data and
that is veracity. [Meyfroidt et al., 2009] discuss the problem of data accuracy and
how it is hard to be measured in retrospect. Accuracy is understood as the ability of
collected data to properly describe the clinical continuum during the time they were
collected. It has two aspects to it: completeness, referring to how much data were
actually collected and how much are missing, and correctness, which is capturing
both whether the code or amount recorded in the system has the correct value and
whether the diagnoses or prescriptions recorded capture what has truly happened.
4Most recently, people consider value as the fifth “V” big data dimension, which refers
to the business potential of achieving greater value through insights from superior
analytics. [Chen et al., 2012] highlight the increasing demand for individuals that
know how to manage the three perspectives of business decision making: descriptive,
predictive and prescriptive analytics.
1.1.3 How Can Big Data Benefit the Medical Domain?
The big data transformation of healthcare can potentially have a positive impact on
all key components of the system, i.e., provider, payer, patient and management.
Essentially, the benefits originate from being able to provide the most suitable in-
tervention at the most appropriate time for each individual patient. [Murdoch and
Detsky, 2013] present examples of illustrative beneficial directions.
First, big data have a great potential on generating new knowledge and advanc-
ing medical research: (i) clinical data could be used for discovering phenotypes and
treatment of patients; (ii) EHRs could potentially establish new patient-stratification
techniques and reveal unknown disease correlations; and (iii) integrating EHRs with
genetic data could provide insights into the genotype /phenotype relationships [Jensen
et al., 2012].
Second, big data may support knowledge dissemination in clinical care. Standard
medical practice is gradually becoming more evidence-based shifting away from sub-
jective decision making. However, most physicians struggle to stay updated with the
latest evidence that is guiding clinical practice. The digitalized format of medical lit-
erature articles facilitates access to knowledge, however the large number of available
information hinders it. A medical diagnostic decision support system (MDDSS or
else called clinical decision support system CDSS) that analyzes real-time data and
provides recommendations could not only be a helpful tool to physicians, but reduce
costs and contribute to standardization of care as well.
5Third, big data slowly shift healthcare towards a model in which the patient is
empowered with a more active role. Patients will no longer always have to visit the
doctor and passively receive advice and treatment. By using smartphone devices,
fitness trackers, or health applications, they could take some measurements on their
own and also improve their health-related data (e.g., medication list, family history)
by linking them to other personal data (e.g., income, education, dietary habits, exer-
cise). By maintaining a digital medical history that always resides with them, patients
obtain greater control over their health. Based on the individual’s history, big data
offer the capability of creating an indicator in a patient-directed way of whether the
patient could be targeted and participate in public health initiatives, to reduce for
example smoking or obesity. Taking it one step further, big data could also contribute
to the medicine development process. People will be able to better evaluate in a more
direct way a drug, since analyzing large patient populations data and making results
available is feasible.
1.1.4 Applications of Machine Learning to Medical Problems
There is a number of papers in the literature that examine the application of data
analytics techniques to healthcare problems. [Raghupathi and Raghupathi, 2014] men-
tion as examples: detecting diseases at earlier stages (e.g., [Li et al., 2007], [Moore
et al., 2013]; managing population health by detecting vulnerabilities within patient
populations during disease outbreaks or disasters (e.g., [Wong et al., 2002]), predict-
ing outcomes, such as length of stay, based on historical data (e.g., [Hachesu et al.,
2013], [Frost et al., 2017], [Pathak et al., 2013], [Hrovat et al., 2014]); forecasting ill-
ness/disease progression (e.g., [Rizk-Jackson et al., 2011]); discovering causal factors
for co-morbid conditions (e.g., [Diamond and Sekhon, 2013]); reducing readmissions
(e.g., [Bayati et al., 2014]); improving outcomes by examining at-home health mon-
itors (e.g., [Costa et al., 2012], [Rodr´ıguez-Mart´ın et al., 2017], [Forkan and Khalil,
62017]); combining clinical, financial and operational data to analyze resource utiliza-
tion productively and in real time (e.g., [IBM, 2013]).
[Obenshain, 2004] discuss the mining applications in the drug discovery process
(e.g., [Burbidge et al., 2001]), infection control surveillance [Brossette et al., 2000],
ranking hospitals and healthcare plans [Cerrito et al., 2002] and identifying high-risk
patients [Ridinger, 2002]. [Koh et al., 2011] refer to how machine learning can help
healthcare insurers detect fraud and abuse (e.g., [Tomar and Agarwal, 2013], [Boxwala
et al., 2011]), healthcare organizations make customer relationship management deci-
sions (e.g., [Paddison, 2000]), physicians identify effective treatments and best prac-
tices, and patients receive better and more affordable healthcare services (e.g., [Groves
et al., 2013]).
[Magoulas and Prentza, 2001] discuss the use of ML for extracting medical knowl-
edge for outcome research (e.g., [Phan et al., 2017]), therapy planning and individ-
ualized support (e.g., [Tuarob et al., 2017]), interpretation of continuous data used
in the Intensive Care Unit (e.g., [Kim et al., 2011]), and medical diagnostic reason-
ing (e.g., [Stausberg and Person, 1999]). Even more examples of applications can be
found in [Meyfroidt et al., 2009], [Yoo et al., 2012] and [Dua et al., 2014].
1.1.5 Challenges and Concerns
The challenges encountered in using analytics with big healthcare data do not only
concern volume, heterogeneity, complexity and uncertainty [Fan et al., 2014]. There
are major concerns especially tied to the medical domain.
First, there is the problem of data privacy, i.e., who has access to patients per-
sonal information and under what conditions. In the U.S., the law that provides a
standard for medical privacy is the Health Insurance Portability and Accountability
Act (HIPAA), voted in 1996. Removing a set of protected health information (PHI)
ensures HIPAA compliance and allows querying the data. Examples of PHI identifiers
7are names, social security numbers, medical records numbers, dates (other than year)
and geographical identifiers smaller than a state. Even though there is regulation
in place and security measures are taken in health institutions to protect medical
data, the healthcare industry is experiencing a number of data breaches. According
to the Identity Theft Resource Center’s reports, in 2013 the health sector breaches
represented 43% of the total overall breaches, with the percent increasing to 44.1% in
2014 and dropping to 35.5% in 2015. The 2013 health sector data breaches impacted
1.84 million Americans and the average victim held liable for more than $18, 600 in
medical services, according to the Ponemon Institutes 2013 Survey on Medical Iden-
tity Theft. Clearly, even with the patients identities blinded, the risk of a central
data repository being compromised renders data privacy an important concern and
medical data sharing challenging.
Another impeding factor for healthcare to embrace the benefits of big data is that
all stakeholders must recognize the value of analytics and be willing to act on its
insights and this is a fundamental change in mentality. Diagnostic decision support
systems (DDSS) have been developed for and used by physicians. Studies have in-
dicated that although physicians acknowledge the need for diagnostic support, they
rarely alter their diagnostic judgment based on recommendations by the system [Rid-
derikhoff and van Herk, 1997], [Ridderikhoff and van Herk, 1999], [Rosenbloom et al.,
2004]. Moreover, there are entities within the health sector that do not deliver direct
individual patient care, such as health service researchers, pharmaceutical compa-
nies, public health or other government organizations, who yet do not exploit big
data due to a lack of coherent policies and standard good practices for secondary
use of health data [Safran et al., 2007]. While at first, there might have not been
strong enough incentives for the adoption of algorithmic approaches in practice, the
healthcare industry nowadays has been transitioning from a fee-for-service to a value-
8based reimbursement model, which is mandating better care at a lower cost. Health
providers that cannot achieve the required quality-of-care scores, face significant fi-
nancial penalties. This, together with the realization of the business benefits of big
data, are driving the required mindset shift. The combination of physicians and data-
driven assistance in clinical practice deserves further and thorough exploration. To
that end, it is of critical importance for the proposed algorithmic big data solutions
to be as much as possible accessible to and comprehensible by the physicians.
1.1.6 Methodologies: What is Needed, What Works, What Matters
There is a number of established and emerging machine learning paradigms for health-
care informatics. Successful application of ML in healthcare problems, requires ac-
curacy, transparency, ability to deal with complex data (often imbalanced, of low
or very large sample size, of high dimensionality, including missing data, of varying
time intervals), ability to incorporate background knowledge to the model, and time
efficiency. More than that, algorithms need to be robust, since they often deal with
life or death decisions.
As nicely suggested in [Kohavi et al., 1997], it is useful to “take each algorithm for
a test drive” and keep in mind the criteria of classification accuracy, comprehensibility,
compactness, training and classification time. For the medical domain in particular,
accuracy is important, but also interpretability is a paramount quality that machine
learning methods should aim to achieve [Vellido et al., 2012]. Sparse classifiers are
interpretable, since they provide feedback on how important each feature is. Based
on this feedback, one can often remove many non-predictive variables from a model
without any significant loss in accuracy, highlighting at the same time features that
most affect the classification decision. We will extensively experiment with and show
the advantages of sparse classifiers in this thesis. While harder to interpret than
linear and sparse algorithms, ensemble methods that build collections of classifiers,
9such as boosting and random forests, can model non-linear relationships, have proven
to provide more accurate models for common healthcare problems, including the one
we study in this thesis, and run quite quickly. We will also explore other models,
such as Naive-Bayes classifiers, which seem to perform well in the medical domain
[Kononenko, 1993], and logistic regression [Wu et al., 2010].
Last, it is our belief that the increasing volume of available healthcare data and the
concerns about data privacy will cause a paradigm shift in data sharing and healthcare
analytics towards a distributed computing model. Such a scheme is more scalable
compared to a single or centralized computing site and, given security measures are
in place, it has many key benefits: greater statistical power due to the large number
of samples and ability to (a) study occurrences of rare outcomes, uptake or usage of
new drugs or therapies, and diverse populations of individuals, (b) combine sources of
data to develop novel analytic and statistical methods, and (c) alleviate data holders
concerns over data security, patient privacy and proprietary interests [Popovic, 2015].
This thesis explores this research direction too.
1.2 Thesis Goal: Predict Chronic Disease Hospitalizations
The key problem we will address in this thesis is to explore and develop centralized
and distributed methods to predict hospitalizations (i.e., admissions to the hospital)
during a target year for patients with heart-related diseases or diabetes based on their
medical history as described in their Electronic Health Records.
Diseases of the heart have been consistently among the top causes of death. In the
U.S., heart disease is yearly the cause of one in every four deaths, which translates
to 610,000 people, while every year, about 735,000 Americans have a heart attack
[Centers for Disease Control and Prevention, 2015]. At the same time, diabetes is
recognized as the worlds fastest growing chronic condition. One in eleven adults has
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diabetes worldwide (415 million) and 12% of global health expenditures is spent on
diabetes ($673 billion) [International Diabetes Federation, 2015]. In the U.S. alone,
29.1 million people or 9.3% of the population had diabetes in 2012 [Centers for Disease
Control and Prevention, 2014]. Given its impact, medical and health services studies
have been tracking the prevalence and trends in diabetes among adults [Menke et al.,
2015,King et al., 1998,Rathmann and Giani, 2004]. While heart diseases and diabetes
affect primarily the patients at many levels (physical, financial, etc.), they also pose
an economic burden to states influencing healthcare costs and GDP/productivity
metrics.
According to [Jiang et al., 2009], nearly $30.8 billion in hospital care cost during
2006 was preventable. Heart diseases and diabetes were the leading contributors ac-
counting correspondingly for more than $9 billion, or about 31% and for almost $6
billion, or about 20%. Clearly, even modest percentage reductions in these amounts
matter. This motivates our research to predict heart and diabetes-related hospitaliza-
tions. Two key enablers to such research are the availability of patient EHRs and the
existence of sophisticated (machine learning) algorithms that can process and learn
from the data.
Our algorithms consider the history of a patient’s records and predict whether
each individual patient will be hospitalized in the following year, thereby, alerting
the health care system and potentially triggering preventive actions. An obvious
advantage of our algorithmic approach is that it can easily scale to a very large
number of monitored patients; such scale is not possible with human monitors.
In Chapter 2, we provide a detailed description of the two datasets we will be
experimenting with in this thesis, namely the dataset of patients with heart-related
diseases and the dataset of patients with diabetes. The EHRs come from Boston
Medical Center, the largest safety-net hospital in Boston. We formulate the problem
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as a binary classification problem and seek to differentiate between patients that will
be hospitalized in a target year and those who will not. Chapters 3 and 4 explore
methods that separate the two classes of samples (patients) using a single classifier.
Specifically, in Chapter 3 we explore a set of baseline methods and we evaluate their
performance in terms of prediction accuracy and interpretability of the model and the
results. Baseline methods include well-established methods, such as Support Vector
Machines, AdaBoost with trees as the weak learner, logistic regression, and also a
novel likelihood ratio based method we develop, K-LRT, that identifies the K most
significant features for each patient that lead to hospitalization.
We continue the analysis in Chapter 4 by developing a distributed cluster Pri-
mal Dual Splitting (cPDS) method, that is computationally efficient and privacy-
aware. Such a distributed leaning scheme is relevant for multi-institutional (e.g.,
hospitals) collaborations or peer-to-peer (e.g., patients’ smartphones) applications,
allowing the“agents” to collaborate, while keeping every participant‘s data private.
We also show that cPDS has an improved convergence rate compared to existing
centralized and decentralized methods. We test all methods in Chapters 3 and 4 in
the heart disease dataset.
In Chapter 5, assuming that the positive class consists of multiple clusters (hos-
pitalized patients due to different reasons), while the negative class is drawn from
a single cluster (non-hospitalized patients healthy in every aspect), we present an
alternating optimization approach, which jointly discovers the clusters in the positive
class and optimizes the classifiers that separate each positive cluster from the negative
samples. We also establish the convergence of the method, characterize its VC di-
mension and present experimental results on both the heart disease and the diabetes
datasets. Lastly, we conclude in Chapter 6 with our key findings in this thesis and
we discuss potential future research directions for this work.
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1.3 Position in the Literature
To the best of our knowledge, the problem of chronic disease hospitalization prediction
using ML methods is novel. A closely related problem, which has received a lot of
attention in the literature, is the re-hospitalization prediction, since around 20% of all
hospital admissions occur within 30 days of previous discharge. Medicare penalizes
hospitals that have high rates of readmissions, especially among patients with heart
failure, heart attack and pneumonia. Identifying patients at risk of readmission can
guide efficient resource utilization and can potentially save millions of healthcare
dollars each year. Examples of work on this problem include [Hosseinzadeh et al.,
2013], [Zolfaghar et al., 2013], [Strack et al., 2014] and [Caruana et al., 2015].
Other related problems are: predicting the onset of diabetes using artificial neural
networks [Pradhan and Sahu, 2011], developing an intelligent system that predicts,
using data mining techniques, which patients are likely to be diagnosed with heart
disease [Palaniappan and Awang, 2008] (it can answer complex queries for diagnos-
ing heart disease and thus assist healthcare practitioners to make intelligent clinical
decisions, which traditional decision support systems cannot), and using data mining
techniques to predict length of stay in cardiac patients (with decision trees, support
vector machines and artificial neural networks) [Hachesu et al., 2013] or in acute
pancreatitis (with artificial neural networks) [Pofahl et al., 1998].
As the last related problem, let us mention the Heritage Health Prize, a competi-
tion by Kaggle, whose goal was to predict the length of stay for patients who will be
admitted to a hospital within the next year, using historical claims (insurance) data
and data mining techniques [Heritage Provider Network, 2011].
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1.4 Our Contributions
• In terms of the application field, we explore a novel, to the best of our knowledge,
problem, that of predicting chronic disease hospitalizations, using centralized or
distributed machine learning methods that we develop. We analyze the results
of the various methods in terms of accuracy and interpretability.
• We show that the accuracy rates achieved by our computational methods sur-
pass what is possible with more empirical but well accepted risk metrics, such as
a heart disease risk factor that emerged out of the Framingham study [D’Agostino
et al., 2008]. We show that even a more sophisticated use of the features used
in the Framingham risk factor, still leads to results inferior to our approaches.
This suggests that the entirety of a patient’s EHR is useful in the prediction
and this can only be achieved with a systematic algorithmic approach.
• We develop a likelihood ratio based method, K-LRT, that is able to identify the
K most significant features for each patient that lead to hospitalization. K-LRT
is proven to achieve high accuracy providing at the same time interpretability
to the results.
• We propose a decentralized optimization scheme (cPDS) for solving the sparse
Support Vector Machines problem. Advantages of this scheme include the scal-
ability and the fact that it avoids raw data exchange, which are crucial for
applications in domains like healthcare. We also prove that cPDS has improved
convergence rate compared to alternatives. The cPDS framework is general and
can be applied to solve other problems that follow the “nonsmooth+nonsmooth”
minimization structure. Such problems can be found in machine learning, where
we aim to minimize functions with non-smooth reguralizers, or in distributed
model predictive control.
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• We apply cPDS to the sparse SVM problem and illustrate its efficiency on
the real healthcare problem we are studying at this thesis, that is aiming to
differentiate between patients that are likely or not likely to be hospitalized
within a target year.
• We propose a novel method, an alternating optimization approach, which jointly
discovers the clusters in the class of hospitalized patients and optimizes the clas-
sifiers that separate each cluster of hospitalized patients (positive class) from the
non-hospitalized patients (negative class). We establish the convergence of this
joint clustering/ classification process and characterize its Vapnik-Chervonenkis
(VC) dimension; a metric of complexity of the classification function that can
lead to generalization guarantees.
1.5 Bibliographic Notes
Large part of the thesis appears in published or working research papers: [Dai et al.,
2014], [Dai, 2015], [Dai et al., 2015], [Xu et al., 2016], [Brisimi et al., 2016] and [Brisimi
et al., 2017] .
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Chapter 2
Datasets: Electronic Health Records of
patients with heart diseases or diabetes
The purpose of this chapter is to describe in detail the two datasets that will be
used throughout the thesis. The first dataset contains the medical history of patients
who have at least one heart-disease diagnosis, while the second dataset contains the
medical history of patients who have at least one diabetes mellitus diagnosis. Both
datasets are extracted from the Boston Medical Center. A survey by the Ameri-
can Hospital Association showed that adoption of EHRs has doubled from 2009 to
2011, partly a result of funding provided by the Health Information Technology for
Economic and Clinical Health Act of 2009 [Charles et al., 2012]. Indeed, in the two
datasets we compile, we observe an abundance of EHRs after 2007, with the number
of EHRs increasing every year.
2.1 Heart Diseases Dataset
2.1.1 Detailed Data Description
The data we used are from the Boston Medical Center (BMC) - the largest safety-
net hospital in New England. The study is focused on patients with at least one
heart-related diagnosis or procedure record in the period 01/01/2005–12/31/2010.
For each patient in the above set, we extract the medical history (demographics, visit
history, problems, medications, labs, procedures and limited clinical observations)
for the period 01/01/2001–12/31/2010, which contains relevant medical factors and
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from which the features of the dataset will be formed. Data were available from the
hospital EHR and billing systems. The ontologies, along with the number of factors
and some examples corresponding to each, are shown in Table 2.11. We note that
some of the Diagnoses and Admissions are not directly heart-related, but may be
good indicators of a heart problem. Overall, our data set contains 45,579 patients
(60% of which compose the training set and the rest the test set).
Our objective is to leverage past medical factors for each patient to predict whether
she/he will be hospitalized or not during a target year which could be different for
each patient.
Ontology
Number
of Factors
Examples
Demographics 4 Sex, Age, Race, Zip Code
Diagnoses 22
e.g., Acute Myocardial Infarction (ICD9: 410),
Cardiac Dysrhythmias (ICD9: 427), Heart Fail-
ure (ICD9: 428), Acute Pulmonary Heart Dis-
ease (ICD9: 415), Diabetes Mellitus with Com-
plications (ICD9: 250.1-250.4, 250.6-250.9),
Obesity (ICD9: 278.0)
1ICD9 (International Classification of Diseases, 9th revision), CPT (Current Procedural Ter-
minology), LOINC (Logical Observation Identifiers Names and Codes), and MSDRG (Medicare
Severity-Diagnosis Related Group) are commonly used medical coding systems for diseases, proce-
dures, laboratory observations, and diagnoses, respectively.
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Procedures CPT 3
Cardiovascular Procedures (including CPT
93501, 93503, 93505, etc.), Surgical Procedures
on the Arteries and Vein (including CPT 35686,
35501, 35509, etc.), Surgical Procedures on the
Heart and Pericardium (including CPT 33533,
33534, 33535)
Procedures ICD9 4
Operations on the Cardiovascular System
(ICD9: 35-39.99), Cardiac Stress Test and pace-
maker checks (ICD9: 89.4), Angiocardiography
and Aortography (ICD9: 88.5), Diagnostic Ul-
trasound of Heart (ICD9: 88.72)
Vitals 2
Diastolic Blood Pressure, Systolic Blood
Pressure
Lab Tests 4
CPK (Creatine phosphokinase) (LOINC:2157-
6), CRP Cardio (C-reactive protein)
(LOINC:30522-7), Direct LDL (Low-density
lipo-protein) (LOINC:2574-2), HDL (High-
density lipoprotein) (LOINC:9830-1)
Tobacco 2
Current Cigarette Use, Ever Cigarette Use
Visits to the ER 1
Visits to the Emergency Room
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Admissions 17
e.g., Heart Transplant or Implant of Heart
Assist System (MSDRG: 001, 002), Cardiac
Valve and Other Major Cardiothoracic pro-
cedures (MSDRG: 216-221), Coronary By-
pass(MSDRG: 231-234), Acute Myocardial In-
farction (MSDRG: 280-285), Heart Failure and
Shock (MSDRG: 291-293), Cardiac Arrest (MS-
DRG: 296-298), Chest Pain (MSDRG: 313),
Respiratory System related admissions (MS-
DRG: 175-176, 190-192)
Table 2.1: Medical Factors in the Heart Diseases Dataset.
In order to organize all the available information in some uniform way for all
patients, some preprocessing of the data is needed to summarize the information over
a time interval. Details will be discussed in the next subsection. We will refer to
the summarized information of the medical factors over a specific time interval as
features.
Each feature related to Diagnoses, Procedures CPT [American Medical Associ-
ation, 2014], Procedures ICD9 [World Health Organization, 1999] and Visits to the
Emergency Room is an integer count of such records for a specific patient during the
specific time interval. Zero indicates absence of any record. Blood pressure and lab
tests features are continuous valued. Missing values are replaced by the average of
values of patients with a record at the same time interval. Features related to tobacco
use are indicators of current- or past-smoker in the specific time interval. Admission
features contain the total number of days of hospitalization over the specific time
interval the feature corresponds to. Admission records are used both to form the
Admission features (past admission records) and in order to calculate the prediction
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variable (existence of admission records in the target year). We treat our problem as a
classification problem and each patient is assigned a label: 1 if there is a heart-related
hospitalization in the target year and 0 otherwise.
2.1.2 Data Preprocessing
In this section we discuss several data organization and preprocessing choices we
make. For each patient, a target year is fixed (the year in which a hospitalization
prediction is sought) and all past patient records are organized as follows.
Summarization of the medical factors in the history of a patient: Based
on experimentation, an effective way to summarize each patient’s medical history
is to form four time blocks for each medical factor with all corresponding records
summarized over one, two, and three years before the target year and all earlier
records being summarized in a fourth block. For blood pressure and tobacco use,
only the year before the target year is kept. This process results to a vector of 212
features for each patient.
Selection of the target year: As a result of the nature of the data, the two classes
are highly imbalanced. When we fix the target year for all patients to be 2010, the
number of hospitalized patients is about 2% of the total number of patients, which
makes the classification problem much more challenging. Thus, and to increase the
number of hospitalized patient examples, if a patient had only one hospitalization
throughout 2007–2010, the year of hospitalization is set as the target year for that
patient. If a patient had multiple hospitalizations, a target year between the first and
the last hospitalization is randomly selected.
Setting the target time interval to be a year: Based on experimentation, a year
has been proven to be an appropriate time interval for prediction. Moreover, given
that hospitalization occurs roughly uniformly within a year, we take the prediction
time interval to be a calendar year.
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Removing noisy samples: Patients who have no records before the target year are
impossible to predict and are thus removed.
2.1.3 Correlation Between Features
The correlation coefficient matrix of all features is shown in Fig. 2·1. Each point (i, j)
corresponds to the correlation coefficient between feature i and feature j. There are
a few features with zero variance (shown as white stripes) that are later removed
from the features set. Most of the features are weakly correlated. There is moderate
correlation between features that refer to the same medical factor but correspond to
different time blocks (near- diagonal elements) and between few other pairs of features
including: Diagnosis of Chronic Ischemic Heart Disease with Diagnosis of Diabetes,
Diagnosis of Ischemic Heart Disease with Diagnosis of Old Myocardial Infarction,
Diagnosis of Heart Failure with Admission due to Heart Failure, and Operations on
Cardiovascular System with Ultrasound of the Heart.
2.2 Diabetes Dataset
2.2.1 Detailed Data Description
The data in this dataset also come from the Boston Medical Center (BMC). The pop-
ulation of the study consists of patients with a Diagnosis record of Diabetes Mellitus
between 01/01/2007–12/31/2012. For each patient in the above set, we extract their
medical history (demographics, visit history, problems, procedures and department
information) for the period 01/01/2001–12/31/2012, which contains relevant medical
factors and from which the features of the dataset will be formed. Data are available
from the hospital EHR and billing systems. The ontologies, along with some examples
corresponding to each, are shown in Table 2.2. As expected, many of the diagnoses
and procedures are direct complications due to diabetes. Diabetes-related admissions
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Figure 2·1: Correlation coefficient between features in the heart dis-
eases dataset.
are not trivially identifiable, and are revealed through the procedure described in the
next subsection. Overall, our data set consists of 40,921 patients (60% of which form
the training set and the rest the test set).
Similarly with the heart-related dataset, our objective is to leverage past medical
factors for each patient to predict whether she/he will be hospitalized or not during
a target year which could be different for each patient. The target year for the never-
hospitalized patients is set to be 2012, so that there is as much possible available
history for them. Patients that have a single hospitalization in a year between 2007-
2012, have this year as their target year. For patients with multiple hospitalizations,
the target year is randomly selected between their first and last hospitalization. The
fraction of hospitalized patients is 16.97%.
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Ontology Examples
Demographics Sex, Age, Race, Zip Code
Diagnoses e.g., Diabetes mellitus with complications, Thyroid disorders,
Hypertensive disease, Pulmonary heart disease, Heart failure,
Aneurysm, Skin infections, Abnormal glycose tolerance test, Family
history of diabetes mellitus
Procedures
(CPT or ICD9)
e.g., Procedure on single vessel, Insertion of intraocular lens
prosthesis at time of cataract extraction, Venous catheterization,
Hemodialysis, Transfusion of packed cells
Admissions e.g., Diabetes (with and without) complications, Heart failure
and shock, Deep Vein Thrombophlebitis, Renal failure, Chest
pain, Chronic obstructive pulmonary disease, Nutritional. & misc
metabolic disorders, Bone Diseases & Arthropathies, Kidney & uri-
nary tract infections, Acute myocardial infarction, O.R. procedures
for obesity, Hypertension
Service by De-
partment
Inpatient (admit), Inpatient (observe), Outpatient, Emergency
Room
Table 2.2: Medical Factors in the Diabetes Dataset.
2.2.2 Identifying the Diabetes-Related Hospitalizations
Identifying the hospitalizations that occur mainly due to diabetes is not a trivial
task, the reason being that many diabetes- related hospitalizations are recorded in
the system as other types of admissions, e.g., heart-related, mostly because of financial
reasons (the billing system charges more for other diseases than diabetes). Therefore,
as a first step we aim to separate the diabetes-related admissions -including diabetes-
related admissions that are labeled otherwise- from all the rest. For that, we consider
all patients with at least one admission record (that indicates hospitalization) between
1-1-2007 and 12-31- 2012. From this set, patients with at least one Diabetes Mellitus
record during 1-1-2007 up to 12-31-2012 are assigned to the diabetic population, while
the rest are assigned to the non-diabetic population.
We list the union of all the unique admission types for both populations (732
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unique types). The total number of admission samples for the diabetic and non-
diabetic populations are N1 = 47, 352 and N2 = 116, 934 correspondingly. For each
type of admission d, each admission sample can be viewed as the outcome of a binary
random variable, that takes the value 1, if the sample hospitalization occurs because
of this type of admission, or 0 otherwise. Thus, we can transform the two sets of
admission records for the two populations into 0/1 sequences. By comparing in the
way described below the proportions of d in the two populations, we can infer whether
admission d was caused mainly by diabetes or not.
At this point, we will elaborate on the statistical hypothesis test used that involves
sample differences of proportions [Sprinthall and Fisk, 1990]. Let P1 and P2 be
the sample proportions obtained in large samples of sizes N1 and N2 drawn from
respective populations p1 and p2. Consider the null hypothesis that the population
parameters are the same (p1 = p2) and thus that the samples are drawn from the same
distribution. The sampling distribution of differences in proportions is approximately
normally distributed, with its mean and standard deviation given by
µP1−P2 = 0 and σP1−P2 =
√√√√√√pq
 1
N1
+
1
N2
, (2.1)
where p = (N1P1 +N2P2)/(N1 +N2) is used as an estimate of the population propor-
tion and where q = 1− p. By using the standardized variable z = (P1−P2)/(σP1−P2)
we can check if the results observed in the samples differ markedly from the results
expected under the null hypothesis. We do that using the single sided p-value of the
statistic z. The p-value is the probability of observing a sample statistic as more
extreme than the one observed under the assumption that the null hypothesis is true.
To interpret that, a small p-value (typically ≤ 0.05) indicates strong evidence against
the null hypothesis. Thus, the smaller the p-value is, the higher the confidence we
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have in the alternative hypothesis or equivalently in the fact that the diabetic patients
have higher chance of getting admission records of type d than the non-diabetic ones
(since we consider the difference P1−P2). After producing the list of increasing order
p-values for each one of the admission types d, we infer that the ones with p-value
≤ α = 1E − 42 are caused by diabetes. Examples of diabetes-related admissions are
shown in Table 2.2.
2.2.3 Data Preprocessing
The features are formed as combinations of different medical factors (instead of con-
sidering the factors as separate features) that better describe what happened to the
patients during their visits to the hospital. Specifically, we formulate triplets that
consist of a diagnosis, a procedure (or the information that no procedure was done)
and the service department. An example of a complex feature (a triplet) is the di-
agnosis of ischemic heart disease that lead to an adjunct vascular system procedure
(procedure on single vessel) while the patient was admitted to the inpatient care.
Clearly, since each category can take one of several discrete values, a huge number of
combinations should be considered. Naturally, not all possible combinations occur,
which reduces significantly the total number of potential features that describe each
patient. Also for each patient, we extract information about the diabetes type over
their history and demographics including age, gender and race. Next, we present
several data organization and pre-processing steps we take. For each patient, a target
year is fixed and all past patient records are organized as follows.
Forming the complex features. We create a diagnoses-procedures indicator ma-
trix to keep track of which diagnosis occurs with which procedure. The procedures
that are not associated with any diabetes-related diagnosis are removed. Procedures
2Apart from selecting a small-value α, we also check the cumulative fraction of patients that are
potentially labeled as belonging to the hospitalized class not to be too small, so that the dataset is
not highly imbalanced.
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in the dataset are listed in the most detailed level of the ICD9 coding system [World
Health Organization, 1999] or the CPT coding system [American Medical Associa-
tion, 2014]. We group together procedures that belong to the same ICD/CPT family,
resulting in 31 categories (out of 2004 in total).
Summarization of the complex features in the history of a patient. Based
on experimentation, an effective way to summarize each patient’s medical history
with a fixed target year is to form four time blocks for each medical factor with all
corresponding records summarized over one, two, three years before the target year
and a fourth time block containing averages of all the earlier records. This produces
a 9402-dimensional vector of features characterizing each patient.
Reducing the number of features. We remove all the features that do not con-
tain enough information for a significant amount of the population (less than 1% of
the patients), as they could not help us generalize. This leaves 320 medical and 3
demographical features.
Identifying the diabetes type. The ICD9 code for diabetes is assigned to category
250 (diabetes mellitus). The fifth digit of the diagnosis code determines the type of
diabetes and whether it is uncontrolled or not stated as uncontrolled. Thus, we have
four types of diabetes diagnoses: type II, not stated as uncontrolled (fifth digit 0), type
I, not stated as uncontrolled (fifth digit 1), type II or unspecified type, uncontrolled
(fifth digit 2) and type I, uncontrolled (fifth digit 3). Based on these four types, we
count how many records of each type each patient had in the four time blocks before
the target year, thus adding 16 new features for each patient.
Setting the target time interval to a calendar year. Based on some preliminary
experiments we conducted, we observed that there is greater variability in the results
when trying to predict hospitalizations in periods of time shorter than a year (e.g.,
predicting hospitalization in the next 1, 3 or 6 months). Thus, we have designed our
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experiment to predict hospitalizations in the target time interval of a year starting
on the 1st of January and ending on the 31st of December.
Selection of the target year. As a result of the nature of the data, the two classes
are highly imbalanced. To increase the number of hospitalized patient examples, if a
patient had only one hospitalization throughout 2007-2012, the year of hospitalization
will be set as the target year. If a patient had multiple hospitalizations, a target year
between the first and the last hospitalizations will be randomly selected. 2012 is set as
the target year for patients with no hospitalization, so that there is as much available
history for them as possible. By this policy, the ratio of hospitalized patients in the
data set is 16.97%.
Removing patients with no record. Patients who have no records before the
target year are removed, since there is nothing on which a prediction can be based.
The total number of patients left is 33,122.
Splitting the data into a training set and a test set randomly. As is common
in supervised machine learning, the population is randomly split into a training and
a test set. Since from a statistical point of view, all the data points (patients fea-
tures) are drawn from the same distribution, we do not differentiate between patients
whose records appear earlier in time than others with later time stamps. A retrospec-
tive/prospective approach appears more often in the medical literature and is more
relevant in a clinical trial setting, rather than in our algorithmic approach. What is
critical in our setting is that for each patient prediction we make (hospitalization/non-
hospitalization in a target year), we only use that patients’ information before the
target year (cf. summarization of patient history above).
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Chapter 3
Baseline Methods; Performance and
Interpretability
To predict whether patients are going to be hospitalized in the target year given
their medical history, we experiment with five different methods. All five are typ-
ical examples of supervised machine learning. We adapt the last one to better fit
the specific application we examine. The first three methods fall into the category
of discriminative learning algorithms, while the latter two are generative algorithms.
Discriminative algorithms directly partition the input space into label regions without
modeling how the data are generated, while generative algorithms assume a model
that generates the data, estimate the model’s parameters and use it to make classi-
fications. Discriminative methods are likely to give higher accuracy, but generative
methods provide more interpretable models and results. This is the reason we ex-
periment with methods from both families and the trade-off between accuracy and
interpretability is observed in our results.
3.1 Support Vector Machines (SVM)
An SVM is a very efficient two-category classifier [Cortes and Vapnik, 1995]. Intu-
itively, the SVM algorithm attempts to find a separating hyperplane in the feature
space, so that data points from the two different classes reside on the different sides
of that hyperplane. We can calculate the distance of each input data point from the
hyperplane. The minimum over all these distances is called margin. The goal of SVM
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is to find the hyperplane that has the maximum margin. In many cases data points
are neither linearly nor perfectly separable. To that end, one can make the classi-
fier tolerant to some misclassification errors (soft-margin SVMs) and leverage kernel
functions to “elevate” the features into a higher dimensional space where linear sepa-
rability is possible (kernelized SVMs) [Cortes and Vapnik, 1995]. Given training data
xi ∈ Rd and labels yi ∈ {−1, 1}, i = 1, . . . , n, soft-margin SVMs find the classifier
(β, β0), β ∈ Rd, β0 ∈ R by solving:
min
β,β0,ξi
0.5‖β‖2 + C∑ni=1 ξi
s. t. ξi ≥ 0, ∀i
yi(x
ᵀ
iβ + β0) ≥ 1− ξi, ∀i
(3.1)
where C is a tunable parameter and ξi is the penalty that will be imposed if point
(xi, yi) is misclassified. Kernelized SVMs use K(xi,xj) = φ(xi)
Tφ(xi) as a kernel for
some feature mapping function φ and solve an optimization problem that is based on
the dual of (3.1) to find the optimal (β, β0). In our application, we employ the widely
used Radial Basis Function (RBF) K(xi,xj) = exp(−‖xi−xj‖2/2σ2) [Scholkopf et al.,
1997] as the kernel function in our experiment settings. Tuning parameters are the
misclassification penalty coefficient C and the kernel parameter σ; we used the values
[0.3, 1, 3] and [0.5, 1, 2, 7 15, 25, 35, 50, 70, 100], respectively. Optimal values of 1
and 7, respectively, were selected by cross-validation.
3.2 AdaBoost with Trees
Boosting [Freund et al., 1999] provides an effective way of combining decisions of not
necessarily strong classifiers to produce highly accurate predictions. The AdaBoost
algorithm iteratively adjusts the weights of various training data points through an
exponential up-weighting or down-weighting procedure. Specifically, starting with
equal weights, the algorithm generates in every iteration a new base classifier to best
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fit the current weighted samples. Then, the weights are updated so that the mis-
classified samples are assigned higher weights so as to influence the training of the
next base classifier. At termination, a weighted combination of the base classifiers
is the output of AdaBoost. In our study we use stumps, which are two-level Clas-
sification and Regression Trees (CART), as the base classifier [Hastie et al., 2009].
This method recursively partitions the space into a set of rectangles and then fits
a prediction within each partition. There is an extra preprocessing step applied to
the data. The zip code values are clustered into 4 clusters using the k-means algo-
rithm [Hastie et al., 2009] and this feature is treated as a categorical one. Moreover,
we used cross-validation to set to 100,000 the number of Adaboost iterations.
3.3 Logistic Regression
Logistic Regression [Bishop et al., 2006] is a popular classification method in real
applications. This method models the posterior probability that a sample falls into
a certain class (e.g. positive class) as a logistic function and the input of this logistic
function is the linear combination of the input features. Under this model, the log-
likelihood ratio of the posterior probabilities of the two classes is a linear function of
the input features. Therefore, the decision boundary that separates the two classes
is still linear. However, beyond the classification decision, the prediction on a certain
sample point naturally comes with a probability value, which could be meaningful in
many applications. Thus, logistic regression is widely used.
3.4 Na¨ıve Bayes Event Model
Na¨ıve Bayes models are generative models that assume the features or “events” to
be generated independently (na¨ıve Bayes assumption [McCallum et al., 1998]). Na¨ıve
Bayes classifiers are among the simplest models in machine learning, but despite their
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simplicity, they work quite well in real applications. There are two types of na¨ıve
Bayes models [McCallum et al., 1998]. The first one will be presented extensively in
the next method. The second one, referred to as the Na¨ıve Bayes Event Model, works
as follows. To generate a new patient from the model, a label y will first be generated
(hospitalized or non-hospitalized) based on a prior distribution p(y). Then, for this
patient, a sequence of events (xt ’s) is generated by choosing each event independently
from certain multinomial conditional distributions p(x|y). An event can appear many
times for a patient and the overall probability of this newly generated patient is the
product of the class prior with the product of the probabilities of each event. In
our problem, an event is a specific combination of the medical factors. We consider
only the medical factors from the following six ontologies: Diagnoses, Admissions,
Emergency, Procedures CPT, Procedures ICD9, and Lab Tests. To generate such a
data set, we aggregate the medical factors that belong to each one of these types and
count the total number of records of the same type in each of the four time blocks
discussed earlier that represent a patient’s history. Thus, each patient is represented
as a sequence of four events. To make events more intuitive and to reduce the total
number of possible events, the data just formed are quantized into binary values and
then the tuples of the six binary values (one for each ontology) are encoded into
single values. We estimate the prior distribution of labels p(y) and the conditional
distributions p(x|y) from the training set and make predictions for the test set based
on the likelihoods calculated from these distributions.
3.5 K-Likelihood Ratio Test
The Likelihood Ratio Test (LRT) is a Na¨ıve Bayes classifier and, as described be-
fore, assumes that features xi are independent. For this method as well, we quantize
the data as shown in Table 3.1. In the quantized data set, the LRT algorithm em-
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Features Levels of
quantiza-
tion
Comments
Sex 3 0 represents missing information
Age 6 Thresholds at 40, 55, 65, 75 and 85 years old
Race 10
Zip Code 0 Removed due to its vast variation
Tobacco (Current and
Ever Cigarette Use)
2 Indicators of tobacco use
Diastolic Blood Pres-
sure (DBP)
3 Level 1 if DBP < 60mmHg, Level 2 if 60mmHg
≤ DBP ≤ 90mmHg and Level 3 if DBP >
90mmHg
Systolic Blood Pres-
sure (SBP)
3 Level 1 if SBP < 90mmHg, Level 2 if 90mmHg
≤ SBP ≤ 140mmHg and Level 3 if SBP >
140mmHg
Lab Tests 2 Existing lab record or Non-Existing lab record
in the specific time period
All other dimensions 7 Thresholds are set to 0.01%, 5%, 10%, 20%,
40% and 70% of the maximum value of each
dimension
Table 3.1: Quantization of Features.
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pirically estimates the distribution p(xi|y) of each feature for the hospitalized and
the non-hospitalized class. Given a new test sample z = (z1, z2, · · · , zn), LRT cal-
culates the two likelihoods p(z|y = 1) and p(z|y = 0) (y = 0 corresponds to non-
hospitalized and y = 1 to hospitalized) and then classifies the sample based on
the ratio p(z|y = 1)/p(z|y = 0). Due to independence, p(z|y = 1)/p(z|y = 0) =∏n
i=1 p(zi|y = 1)/p(zi|y = 0). In our variation of the method, which we will call
K-LRT, instead of taking into account the ratios of the likelihoods of all features,
we consider only the K features with the largest ratios. This type of method is
closely related to the anomaly detection methods in [Saligrama and Zhao, 2012]. The
purpose of this “feature selection” is to identify the K most significant features for
each individual patient. Thus, each patient is actually treated differently. After ex-
perimentation, the best performance is achieved by setting K = 4. The prediction
accuracy for K = 1 is also reported in the experimental results section.
3.6 Experimental Results on the Heart Disease Dataset
Typically, the primary goal of learning algorithms is to maximize the prediction ac-
curacy or equivalently minimize the error rate. However, in the specific medical
application problem we study, the ultimate goal is to alert and assist doctors in tak-
ing further actions to prevent hospitalizations before they occur, whenever possible.
Thus, our models and results should be accessible and easily explainable to doctors
and not only machine learning experts. With that in mind, we examine our models
from two aspects: prediction accuracy and interpretability.
3.6.1 Prediction Accuracy
The prediction accuracy is captured in two metrics: the False Alarm Rate (the fraction
of false positives out of the negatives) and the Detection Rate (the fraction of true
positives out of the positives). Note that in the medical literature, the detection rate
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is often referred to as sensitivity and the term specificity is used for one minus the false
alarm rate. For a binary classification system, the evaluation of the performance using
these two metrics is typically illustrated with the Receiver Operating Characteristic
(ROC) curve, which plots the Detection Rate versus the False Alarm Rate at various
threshold settings.
We first compare the performance of LRT using all features and K-LRT under
different values of K. Fig. 3·1 shows the prediction accuracy for LRT, 1-LRT and 4-
LRT. In Fig. 3·2, a comparison of the performance of all five methods we presented is
illustrated. We also generate the ROC curve based on patients’ 10-year risk of General
Cardiovascular Disease defined in the Framingham Heart Study (FHS) [D’Agostino
et al., 2008]. FHS is a seminal study on heart diseases that has developed a set of
risk factors for various heart problems. The 10-years risk we are using is the closest
to our purpose and has been widely used. We calculate this risk value (which we
call the Framingham Risk Factor-FRF ) for every patient and make the classification
based on this risk factor only. We also generate an ROC by applying the AdaBoost
with trees method just to the features involved in FRF. The generated ROC serves
as a baseline for comparison.
Based on the experimental results, we draw the following conclusions:
1. LRT, 1-LRT and 4-LRT achieve very similar performance. This indicates that
using only the most significant or several significant features with the largest
likelihood ratios, is sufficient in making an accurate prediction. It also suggests
that our problem is close to an “anomaly detection” problem and identifying
the most anomalous feature captures most of the information that is useful for
classification.
2. From the comparison of all five methods in Fig. 3·1, it can be seen that AdaBoost
is the most powerful one and performs the best except for situations that require
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Figure 3·1: Comparison of LRT, 1-LRT and 4-LRT.
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Figure 3·2: Comparison of all five methods and the methods based
on the Framingham Heart Study.
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very low False Alarm Rates. On the other hand, the Na¨ıve Bayes Event classifier
generally performs the worst due to its simplicity.
3. The performance of RBF SVM, Logistic Regression, AdaBoost with trees, and
4-LRT is quite similar in general. However, these methods have very different
assumptions and underlying math formulation. Based on this observation, we
conjecture that we have approached the limit of the prediction accuracy that
could be achieved with the available data.
4. All of our proposed methods perform better than utilizing the FRF, except for
the na¨ıve Bayes event classifier for high false alarms rates. Even by applying
AdaBoost with Trees (the best method so far) to the features involved in calcu-
lating the FRF, does not seem to help a lot. This suggests that it is valuable to
have and leverage a multitude of patient-specific features obtained from EHRs.
Using these data, however, necessitates the use of the algorithmic approach we
advocate.
3.6.2 Interpretability
With SVM, the features are mapped through a kernel function from the original space
into a higher-dimensional space. This, however, makes the features in the new space
not interpretable. In AdaBoost with trees, while a single tree classifier which is used
as the base learner is explainable, the weighted sum of a large number of trees makes
it relatively complicated to find the direct attribution of each feature to the final
decision. The na¨ıve Bayes Event model is in general interpretable, but in our specific
problem each patient has a relatively small sequence of events (four) and each event
is a composition of medical factors. Thus, again, to find the direct attribution of
each feature to the final decision is hard. LRT itself and Logistic Regression still lack
interpretability, because we have more than 200 features for each sample and there
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is no direct relationship between prediction of hospitalization and the reasons that
led to it. The most interpretable method is K-LRT. K-LRT highlights the top K
features that lead to the classification decision. These features could be of help in
assisting the physicians reviewing the patient’s EHR profile.
Below we present the features highlighted by two of our methods: 1-LRT and
Adaboost. We remind the reader that in 1-LRT, each test patient is essentially
associated with a single feature. For all features, we count how many times they
were selected as the primary feature and we report in Table 3.2 the 10 features that
were the most popular as primary. Adaboost, on the other hand, yields a linear
combination of decision trees and is hard to interpret. However, we can calculate a
variable Importance Score (IS) [Hastie et al., 2009] for each feature, which highlights
the most significant features. Table 3.3 lists the top 10 important features indicated
by their importance score. Features that appear in both tables are in bold.
The two sets of features highlighted from the two methods have several features
in common, indicating that the results from the different methods are consistent.
This consistency supports the validity of our methods from a stability/sensitivity
perspective as well.
From a medical point of view, the features listed in Table 3.2 and Table 3.3 are
reasonably highlighted. ER visits, a diagnosis of heart failure, and chest pain or other
respiratory symptoms are often precursors of a major heart episode. The CPK test
is also viewed as one of the most important tests for diagnosing Acute Myocardial
Infarction (AMI) and AMI, among all heart diseases, is the most probable to lead to
hospitalization.
To provide additional insight into the algorithms, Table 3.4 presents five more
medically significant features highlighted by each method and two interesting features
with low significance in both methods. For 1-LRT, features with low significance are
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1-LRT 1-LRT
Counts Feature Name
1591 Age
548 Visit to the Emergency Room, 1 year before the target year
525 Diagnosis of hematologic disease, 1 year before the target year
523 Diagnosis of heart failure, 1 year before the target year
514 Symptoms involving respiratory system and other chest symp-
toms, 1 year before the target year
486 Diagnosis of diabetes mellitus w/o complications, 1 year before
the target year
474 Lab test CPK, 1 year before the target year
451 Lab test CPK, 4 years before the target year and the rest of the history
408 Diagnosis of heart failure, 2 years before the target year
356 Diagnosis of diabetes mellitus w/o complications, 2 years before the tar-
get year
Table 3.2: Top 10 significant features for 1-LRT.
the ones with a likelihood ratio p(zi|y = 1)/p(zi|y = 0) close to 1. For Adaboost,
non-significant features have a low IS. It is interesting that Hypertensive heart disease
is considered non-significant by both methods. This is probably due to the fact that,
once diagnosed, it is usually well-treated and the patient’s blood pressure is well-
controlled.
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AdaBoost AdaBoost
IS (×10−4) Feature Name
0.6462 Diagnosis of diabetes mellitus w/o complications, 1 year before the
target year
0.5498 Diagnosis of heart failure, 1 year before the target year
0.4139 Age
0.3187 Symptoms involving respiratory system and other chest
symptoms, 1 year before the target year
0.2470 Admission due to other circulatory system diagnoses, 1 year before
the target year
0.2240 Visit to the Emergency Room, 4 years before the target year and
the rest of the history
0.1957 Operations on cardiovascular system (heart and septa OR vessels
of heart OR heart and pericardium), 4 years before the target year
and the rest of the history
0.1578 Visit to the Emergency Room, 1 year before the target
year
0.1543 Symptoms involving respiratory system and other chest symptoms,
4 years before the target year and the rest of the history
0.1124 Diagnosis of heart failure, 2 year before the target year
Table 3.3: Top 10 significant features for AdaBoost with Trees.
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Another 5 significant fea-
tures in 1-LRT
Another 5 significant fea-
tures in 1-LRT
Lab Test High-density lipoprotein
(HDL)
Lab Test High-density lipoprotein
(HDL), 1 year before the target
year
Lab Test Low-density lipoprotein
(LDL)
Angiography and Aortography
procedures, 4 years before the
target year and the rest of the
history
Systolic Blood Pressure Cardiac Catheterization Proce-
dures, 4 years before the target
year and the rest of the history
Diagnosis of Heart Failure Race
Diagnosis of Other Forms of
Chronic Ischemic Heart Diseases
Cardiac Dysrhythmias, 1 year be-
fore the target year
2 non-significant features in
1-LRT
2 non-significant features in
AdaBoost with Trees
Sex Sex
Hypertensive Heart Disease, 1
year before the target year
Hypertensive Heart Disease, 1
year before the target year
Table 3.4: Other significant and non-significant features with 1-LRT
and AdaBoost with Trees.
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Chapter 4
A Distributed Cluster Primal Dual
Splitting Method for Large-Scale Sparse
Support Vector Machines
As the volume, variety, velocity and veracity (the four V’s) of the clinical data are
growing, there is greater need for efficient computational models to mine these data.
Insights from these techniques could help design efficient healthcare policies, detect
disease causes, provide medical resolutions that are personalized and less costly and
finally, improve the quality of hospital care for the patients. We are motivated by
problems in the medical domain that can be formulated as binary supervised classi-
fication problems and solved using Support Vector Machines; the applications range
from prediction of diabetes disease [Kumari and Chitra, 2013] [Yu et al., 2010], pre-
diction of medication adherence in heart failure patients [Son et al., 2010], automated
recognition of the obstructive sleep apnea syndrome [Khandoker et al., 2009], to our
problem of predicting heart-related hospitalizations. Results in the literature suggest
that sparse classifiers, i.e., relying on few informative features, have strong predictive
power and generalize well out-of-sample, providing at the same time interpretabil-
ity in both models and results, which is crucial in order for healthcare practitioners
to trust the computed solutions. Another major concern, especially in the medi-
cal domain, is the privacy of the data, attracting recent research efforts, including
work on the field of differential privacy [Narayanan and Shmatikov, 2008, Dwork,
2011,Brown et al., 2013]. Two well-known examples of privacy breaches are the Net-
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flix Prize and the Massachusetts Group Insurance Commission (GIC) medical records
database. In both cases, individuals were identified even though the data had been
through a de-identification process. This demonstrated that one’s identity and other
sensitive information could be compromised once a single center has access and pro-
cesses all data. Especially, under the Precision Medicine Initiative, in the near future,
these data could include individuals’ genome information, which is too sensitive to
be shared.
In this part of the thesis, we are particularly interested in addressing three chal-
lenges tied to healthcare data: (1) data reside in different sources (hospitals, health
centers, patients’ smartphones), which implies the need to build a collective intelli-
gence system; (2) there is a growing availability of data, which makes scalable frame-
works rather important; and (3) data privacy is a critical concern. A decentralized
computational scheme that collaboratively utilizes all the data in the network, while
avoiding centralized data collection and coordination, may meet the requirements.
Notational Conventions: All vectors are assumed to be column vectors. xᵀ
represents the transpose of x. For any real matrices (vectors) with appropriate di-
mensions, A and B, the inner product of them is defined as 〈A,B〉 = Trace{AᵀB}.
The Frobenius norm of matrix B = (Bij) is denoted by ‖B‖Fro =
√∑m
i=1
∑n
j=1 |Bij|2.
Suppose M is a real matrix with appropriate dimensions, then an M-weighted norm
of B is defined as ‖B‖M =
√〈B,MB〉. Suppose B is also a square matrix, then
√
B = L
√
SRᵀ where B = LSRᵀ is the singular value decomposition of B. Given an
m×n matrix A and a p× q matrix B, their Kronecker product C = (Cij) = A⊗B is
an (mp)× (nq) matrix with elements defined by Cαβ = AijBkl, where α = p(i−1)+k
and β = q(j − 1) + l. The largest eigenvalue of B is denoted by λmax{B}. The
m-by-m identity matrix is denoted by Im. The relation A 4 B means (B − A)
is positive semidefinite while A ≺ B means (B − A) is positive definite (< and 
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are similarly defined). For any proper, closed, and convex function (could be nons-
mooth/nondifferentiable) f : Rp → R, we use ∂f(x) to denote the subdifferential of
f at x which is actually a convex set. A subgradient of f at x, denoted as ∇˜f(x),
is an element of ∂f(x). Which subgradient we will use in the algorithm will be clear
from the context.
Aim: The focus of this section is to solve in a decentralized manner the soft-
margin `1-regularized (sparse) Support Vector Machines (sSVM) problem [Friedman
et al., 2001]. Given training data φi ∈ Rd and labels li ∈ {−1, 1}, i = 1, . . . , n, we
would like to find the classifier (β, β0), β ∈ Rd, β0 ∈ R by solving:
min
β,β0,ξi
0.5‖β‖2 + C∑ni=1 ξi + κ‖β‖1
s. t. ξi ≥ 0, ∀i
li(φ
ᵀ
iβ + β0) ≥ 1− ξi, ∀i
(4.1)
where C and κ are tunable parameters. If ξi = 0, then 1− li(φᵀiβ + β0) ≤ 0 and the
corresponding term in the objective function is 0. If ξi > 0, then 1− li(φᵀiβ+β0) ≤ ξi
and minimizing ξi in the objective function is equivalent to minimizing 1−li(φᵀiβ+β0).
Thus, formulation (4.1) is equivalent to the following with the tunable parameters
being τ = 1/C and ρ = κ/C:
min
β,β0
∑n
i=1 hi(β, β0) + 0.5τ‖β‖2 + ρ‖β‖1 (4.2)
where each hi(β, β0) = [1− li(φᵀiβ + β0)]+ = max{0, 1− li(φᵀiβ + β0)} is a hinge loss
function corresponding to sample i and the ‖β‖2 and ‖β‖1 terms are regularizers for
the model parameters.
In the distributed context we are interested in a setting where each agent1 holds a
part of the data/samples, namely, a subset of {φi,∀i} and {li,∀i}, and would like to
collaborate with the others to obtain a better estimate on β and β0. Due to privacy
1We will use the generic term “agent” to represent each data/computation center. The term
could refer to institutions, or even individuals.
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concerns, these agents are not willing to share their original data with each other or
with a processing center. Thus, we will pursue a decentralized solution that avoids
raw data exchange.
Related literature: Problem (4.2) involves minimization of the sum of two
convex but non-smooth terms that have the form of a sum:
∑n
i=1[1− li(φiᵀβ+ β0)]+
and
∑n
i=1 {0.5τi‖β‖2 + ρi‖β‖1} where
∑
i τi = τ and
∑
i ρi = ρ. When all the data
are stored and computations are executed in a centralized unit, we can solve the
problem using the interior point (also referred to as barrier) method [Bertsekas, 1999]
or the classical subgradient method (SubGD) [Bertsekas, 1999] .
A recent method for solving regularized empirical risk minimization problem that
features a master-slave type (star network) distributed computing scheme is proposed
in [Zhang and Lin, 2015] (SPDC). For the sSVM problem, such scheme is shown to
have an O(1/k) convergence rate2 with constant step size and supports mini-batch
coordinate updates. However, it cannot be performed in a general decentralized net-
work. When the objectives are strongly convex and smooth (though not applicable
to sSVM), it is proved to have geometric convergence rate. Another approach with
O(1/
√
k) convergence rate that can solve the sSVM and allows a decentralized im-
plementation is the incremental subgradient method (IncrSub). However, IncrSub
needs to deploy vanishing step size to reach exact convergence and only works over
networks containing a ring structure [Nedic and Bertsekas, 2001]. Besides the above
methods that only work in networks with some specific topology, the following op-
timization schemes can be applied to arbitrary undirected communication networks.
The subgradient method introduced in [Nedic and Ozdaglar, 2009] can be directly
used for solving the sSVM. Although this algorithm features an elegant update rule,
its convergence is typically slow due to the use of diminishing step sizes. A re-
2A nonnegative sequence {ak} is said to be convergent to 0 at an O(1/k) rate if lim supk→∞kak <
+∞. In contrast, it is said to have an o(1/k) rate if lim supk→∞kak = 0.
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cent fully decentralized scheme that has made a significant improvement over the
subgradient method is the Linear time Average Consensus optimization algorithm
(LAC) [Olshevsky, 2014]. The LAC algorithm utilizes a fixed but small step size
and is shown to have O(1/
√
k) convergence rate. A good feature of the LAC is that
it improves the algorithmic scalability in the size of the network through utilizing
Nesterov’s acceleration technique [Nesterov, 1983]. There exist other decentralized
optimization frameworks that allow the objective to be nondifferentiable, such as
the Proximal-EXact first order Algorithm (Proximal-EXTRA) algorithm [Shi et al.,
2015b] and the Distributed Alternating Direction Method of Multipliers (DADMM)
algorithm [Bertsekas and Tsitsiklis, 1989]. Under strong convexity and smoothness
assumptions, these methods are proved to have geometric convergence rate, whereas
in the presence of nonsmooth objectives, the convergence rate of these methods is
O(1/k). But since these (proximal) methods are not tailored for problems with “non-
smooth+nonsmooth” structure, their per-iteration cost will be rather expensive if we
apply them to the sSVM directly.
We list in Table 4.1 comparative results that illustrate the trade-offs between dif-
ferent methods, including our proposed cluster Primal Dual Splitting (cPDS) frame-
work, when applied to the sparse SVM problem.3
Table 4.1: Theoretical performance results for all methods for the
sSVM problem
Method Decent- Per iteration -accuracy
ralized? complexity iterations
SubGD × O(nd) O(1/2)
IncrSub × O(d) O(1/2)
SPDC × O(nd) O(1/)
LAC
√
O(n2d) O(1/2)
cPDS
√
O((n+m2)d) o(1/)
3“Per iteration complexity” measures how many scalar multiplications are needed per iteration
when applied for solving sSVM. “-accuracy iterations” measure how many iterations are needed to
reach -accuracy.
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4.1 The Cluster Primal Dual Splitting Method
In this section, we first introduce the general decentralized primal dual spliting scheme
that we have designed for solving “nonsmooth+nonsmooth” optimization problems.
Then we provide convergence analysis for the scheme we have proposed.
Let us assume there is a network of agents, each of which is holding part of the data
and they all collectively would like to solve (4.2) utilizing all data. We consider two
cases: each agent is holding (1) multiple samples (semi-centralized) or (2) one sample
(fully-decentralized) of the data. In the healthcare context, for the first scenario
agents can be hospitals that process the data of their patients only and exchange
messages in order to optimize globally some function, while the second scenario may
correspond to each patient having their data stored and processed in their smartphone
and messages to be exchanged between patients’ phones. In both cases, the m agents
are connected through an underlying communication network, which is modeled by
an undirected graph G = (V , E), where V = {1, 2, . . . ,m} is the vertex set and E is
the edge set. Throughout the paper, we make the following Assumption 1.
Assumption 1. The graph G is connected.
Let W = [wij] be a doubly stochastic matrix generated following the Metropolis
rule on G, i.e.,
wij =

1
max{degree(i),degree(j)}+1 , if (i, j) ∈ E ,
0, if (i, j) /∈ E and i 6= j,
1− ∑
k∈V
wik, if i = j.
Such rule allows each agent i to generate wij,∀j, by only using local information (its
own and neighbors’ degree information). Note that we always have −Im ≺W 4 Im
[Shi et al., 2015a]. Let us also define  L , (Im −W) ⊗ Id+1 and U ,
√
 L. We note
that U has the same null space as  L.
Clearly, in the decentralized environment, problem (4.2) can be reformulated into
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the following m-cluster splitting formulation:
min
β,β0
m∑
j=1
{
nj∑
i=1
[1− yji]+ + 0.5τj‖βj‖2 + ρj‖βj‖1
}
s.t. γji(lji(φ
ᵀ
jiβj + βj0)− yji) = 0,∀j, i;
β1 = β2 = . . . = βm;
β1,0 = β2,0 = . . . = βm0,
(4.3)
where each agent (hospital) j holds nj samples (note that n =
∑m
j=1 nj) and maintains
its own copy of the model parameters to be estimated xj = (βj, βj0) ∈ Rd+1 and τj and
ρj are tunable model parameters. The parameters γji’s are arbitrary nonzero scalar
constants and will serve as algorithmic parameters later in the designed algorithm.
Let us define a long vector x = [x1; . . . ; xm] ∈ Rm(d+1) to compactly represent all
the local copies; a long vector variable y = [y1; . . . ; ym] ∈ Rn where each block
yj = [yj1; . . . ; yjnj ] ∈ Rnj is handled by agent j. We also prepare q ∈ Rn and
λ ∈ Rm(d+1) which will serve as auxiliary (dual) variables later in the algorithm.
Their blocks are handled in parallel by agents and the operations on them will be
clear from the context.
With the above notation, problem (4.3) can be represented in a more compact
form as follows:
min
{xj ,yj}, ∀j
m∑
j=1
{gj(xj) + fj(yj)}
s.t. Γj(Ajxj − yj) = 0, ∀j,
x1 = x2 = . . . = xm,
(4.4)
where the function fj(yj) contains all the hinge loss functions
nj∑
i=1
[1 − yji]+ for agent
j, while the function gj(xj) includes the regularizers 0.5τj‖βj‖2 + ρj‖βj‖1 over agent
j. Each Aj contains all the data samples for agent j (c.f. the corresponding first
group of constraints in (4.3)). Each matrix Γj ∈ Rnj×nj is a diagonal full rank
matrix containing γji,∀i. Each Γj is locally produced/tuned by agent j to possibly
precondition/scale Aj so as to achieve better performance. To solve the cluster sSVM,
or its more general form (4.4), in a decentralized fashion, we propose Algorithm 1.
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Algorithm 1 Cluster PDS Method
Input: ∀j, Prepare data/objectives fj and gj; Set parameters Γj and Θj.
Initialize: ∀j, x0j ∈ Rd+1, y0j ∈ Rnj , q−1j = 0, q0j = Γj(Aᵀjx0j − y0j ), λ−1j = 0, and
λ0j = x
0
j −
∑
i∈Nj∪{j}wjix
0
i .
repeat
x-update (locally): ∀j
xk+1j = arg min
xj
{
(2qkj − qk−1j )T (ΓjAjxj) + gj(xj)
+(2λkj − λk−1j )Txj + 0.5‖xj − xkj‖2Θj
}
y-update (locally): ∀j
yk+1j = arg min
yj
{
fj(yj) + (q
k
j )
T (−Γjyj) + 0.5‖yj −Ajxk+1j ‖2ΓᵀjΓj
}
q-update (locally): ∀j
qk+1j = q
k
j + Γj(Ajx
k+1
j − yk+1j )
λ-update (requires information exchange): ∀j
λk+1j = λ
k
j + x
k+1
j −
∑
i∈Nj∪{j}
wjix
k+1
i
until specific criteria are met.
In the algorithm, Θj ∈ R(d+1)×(d+1) is a diagonal positive definite matrix that
serves as a part of the algorithmic parameters maintained by agent j. Later after the
analysis, we will remark that the algorithmic parameters Γj and Θj can be determined
by agent j fully locally and independently from the network topology.
To facilitate our convergence analysis, let us further write (4.4) into an even more
compact form:
min
x,y
{g(x) + f(y)}
s.t. Γ(Ax− y) = 0,
Ux = 0,
(4.5)
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where g(x) =
m∑
j=1
gj(xj), f(y) =
m∑
j=1
fj(yj) and Γ, A are the matrices/tensors that
contain Γj and Aj correspondingly ∀j = 1, . . . ,m. We note that Ux = 0, where
U ,
√
 L, is equivalent to x1 = x2 = . . . = xm, as long as the graph is connected,
since the null space of U is {x = [x1; x2; . . . ; xm] ∈ Rm(d+1)
∣∣x1 = x2 = . . . = xm}.
Before starting the convergence analysis, let us make two more basic assumptions.
Assumption 2. The functions g : Rm(d+1) → R and f : Rn → R are both proper,4
closed, and convex.
Assumption 3. The solution set χ∗ of (4.5) is nonempty and bounded.
Assumption 2 imposes a minimal requirement on the objectives to conduct convex
analysis. Assumption 3 is obviously satisfied by the sSVM problem.
The augmented Lagrangian function of (4.5) is as follows
L = g(x) + f(y) + 〈r,Ux〉+ 〈q,Γ(Ax− y)〉 (4.6)
where r ∈ Rm(d+1) and q ∈ Rn contain the dual variables. The first-order conditions
for the saddle point of (4.6) are
∇˜g(x∗) + Ur∗ + AᵀΓᵀq∗ = 0; (4.7a)
Ux∗ = 0; (4.7b)
∇˜f(y∗)− Γᵀq∗ = 0; (4.7c)
Ax∗ − y∗ = 0. (4.7d)
Clearly, x∗ ∈ χ∗. The update relations of Algorithm 1 can be recast into the following:
4A function f : X → Y is proper if ∃x in the domain X of f such that f(x) is finite.
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∇˜g(xk+1) + AᵀΓᵀ(2qk − qk−1)
+ U(2rk − rk−1) + Θ(xk+1 − xk) = 0; (4.8a)
∇˜f(yk+1)− Γᵀrk + ΓᵀΓ(yk+1 −Axk+1) = 0; (4.8b)
qk+1 = qk + Γ(Axk+1 − yk+1); (4.8c)
λk+1 = λk +  Lxk+1. (4.8d)
By reorganisation of the updates and by using the optimality conditions, we derive
the following Lemma.
Lemma 1. The recursion of the proposed algorithm obeys
(Θ−AᵀΓᵀΓA−  L)(xk+1 − xk) + AᵀΓᵀΓ(yk+1 − yk)
= −∇˜g(xk+1)−Urk+1 −AᵀΓᵀqk+1; (4.9a)
(Θ−AᵀΓᵀΓA−  L)(xk+1 − xk) + AᵀΓᵀΓ(yk+1 − yk)
= ∇˜g(x∗)− ∇˜g(xk+1) + U(r∗ − rk+1) + AᵀΓᵀ(q∗ − qk+1); (4.9b)
∇˜f(yk+1)− Γᵀqk+1 = 0; (4.9c)
∇˜f(yk+1)− ∇˜f(y∗)− Γᵀ(qk+1 − q∗) = 0; (4.9d)
qk+1 = qk + Γ(A(xk+1 − x∗)− (yk+1 − y∗)); (4.9e)
rk+1 = rk + Uxk+1; (4.9f)
λk = Urk;
rk+1 = rk + U(xk+1 − x∗). (4.9g)
Before stating our main results, let us define a long vector zk ,
[
xk; yk; rk; qk
] ∈
R2m(d+1)+2n and a (2m(d+ 1) + 2n)× (2m(d+ 1) + 2n) block diagonal matrix5 M ,
blkdiag{Θ−AᵀΓᵀΓA−  L,ΓᵀΓ, Im(d+1), In}. Correspondingly, we also define z∗ ,
5We use blkdiag(A,B,C,D), where A, B, C, D are matrices, to denote a block diagonal matrix of
the form
A 0 0 00 B 0 0
0 0 C 0
0 0 0 D
.
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[x∗; y∗; r∗; q∗] ∈ R2m(d+1)+2n.
Theorem 1 (Convergence). If the scaling parameters are chosen such that
Θ−AᵀΓᵀΓA−  L  0, (4.10)
then ‖∇˜f(yk+1)− Γᵀqk+1‖2Fro = 0 and the sequences {‖zk − zk+1‖2M}, {‖∇˜g(xk+1) +
Urk+1+AᵀΓᵀqk+1‖2Fro}, {‖Γ(Axk+1−yk+1)‖2Fro}, and {‖Uxk+1‖2Fro} are all infinitely
summable over k ≥ 0. Consequently, the sequence {xk+1} generated by the proposed
algorithm converges to a consensual6 and optimal solution of problem (4.5) (x part).
Proof. By the convexity of g, we have
0 ≤ 2〈xk+1 − x∗, ∇˜g(xk+1)− ∇˜g(x∗)〉. (4.11)
Substituting (4.9b) into the second term of the right-hand-side of (4.11) for (∇˜g(xk+1)−
∇˜g(x∗)) gives
0
≤ 2〈xk+1 − x∗, ∇˜g(xk+1)− ∇˜g(x∗)〉
= 2〈xk+1 − x∗,−(Θ−AᵀΓᵀΓA−  L)(xk+1 − xk)
−U(rk+1 − r∗)〉+ 2〈xk+1 − x∗,
−AᵀΓᵀΓ(yk+1 − yk)−AᵀΓᵀ(qk+1 − q∗)〉
= 2〈xk+1 − x∗, (Θ−AᵀΓᵀΓA−  L)(xk − xk+1)〉
+2〈U(xk+1 − x∗), r∗ − rk+1〉
+2〈xk+1 − x∗,AᵀΓᵀΓ(yk − yk+1)〉
+2〈xk+1 − x∗,AᵀΓᵀ(q∗ − qk+1)〉.
(4.12)
Next, let us look into the four terms at the right-hand-side of (4.12). The first term
has an appropriate form; For the second term, by (4.9g), we have
2〈U(xk+1 − x∗), r∗ − rk+1〉
= 2〈rk+1 − rk, r∗ − rk+1〉; (4.13)
For the third term, we have
2〈xk+1 − x∗,AᵀΓᵀΓ(yk − yk+1)〉 (by (4.9e))
= 2〈Γ(yk+1 − y∗) + qk+1 − qk,Γ(yk − yk+1)〉 (by (4.9c))
= 2〈yk+1 − y∗,ΓᵀΓ(yk − yk+1)〉
−2〈∇˜f(yk)− ∇˜f(yk+1),yk − yk+1〉
(by the convexity of f)
≤ 2〈yk+1 − y∗,ΓᵀΓ(yk − yk+1)〉;
(4.14)
6All rows of x are equal to each other.
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For the last term, we have
2〈xk+1 − x∗,AᵀΓᵀ(q∗ − qk+1)〉 (by (4.9e))
= 2〈Γ(yk+1 − y∗) + qk+1 − qk,q∗ − qk+1〉 (by (4.9d))
= −2〈yk+1 − y∗, ∇˜f(yk+1)− ∇˜f(y∗)〉+ 2〈qk+1 − qk,
q∗ − qk+1〉 (by the convexity of f)
≤ 2〈qk+1 − qk,q∗ − qk+1〉.
(4.15)
Combining (4.12)–(4.15) and using the definition of M and z, we get
0
≤ 2〈xk+1 − x∗, (Θ−AᵀΓᵀΓA−  L)(xk − xk+1)〉
+2〈yk+1 − y∗,ΓᵀΓ(yk − yk+1)〉
+2〈rk+1 − rk, r∗ − rk+1〉
+2〈qk+1 − qk,q∗ − qk+1〉
= 2〈zk+1 − z∗,M(zk − zk+1)〉
= ‖zk − z∗‖2M − ‖zk+1 − z∗‖2M − ‖zk − zk+1‖2M.
(4.16)
It shows from (4.16) that ‖zk − z∗‖2M is monotonically non-increasing and thus is
bounded. Since z0 and z∗ are bounded, we also have that zk is bounded and thus
‖zk − zk+1‖2M is bounded. It then follows from (4.16) that
∞∑
k=0
‖zk − zk+1‖2M
≤
∞∑
k=0
(‖zk − z∗‖2M − ‖zk+1 − z∗‖2M)
(Telescoping cancellation)
= ‖z0 − z∗‖2M − ‖z∞ − z∗‖2M < +∞,
(4.17)
thus, we conclude that {‖zk − zk+1‖2M} is infinitely summable over k thus
lim
k→+∞
‖zk − zk+1‖2M = 0. (4.18)
Below we will show that zk converges to a point z∞ that satisfies the first-order
optimality condition. Combining (4.9f), (4.17), and (4.18) gives that {‖Uxk‖2Fro} is
infinitely summable and
limk→+∞ ‖Uxk+1‖2Fro = limk→+∞ ‖rk − rk+1‖2Fro = 0; (4.19)
Combining (4.8c), (4.17), and (4.18) gives that {‖Γ(Axk − yk)‖2Fro} is infinitely
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summable and
limk→+∞ ‖Γ(Axk+1 − yk+1)‖2Fro
= limk→+∞ ‖qk+1 − qk‖2Fro = 0; (4.20)
Combining (4.9a), (4.17), and (4.18) gives that {‖∇˜g(xk) + Urk + AᵀΓᵀqk‖2Fro} is
infinitely summable and
limk→+∞ ‖∇˜g(xk+1) + Urk+1 + AᵀΓᵀqk+1‖2Fro
= limk→+∞ ‖(Θ−AᵀΓᵀΓA−  L)(xk+1 − xk)
+AᵀΓᵀΓ(yk+1 − yk)‖2Fro≤ limk→+∞ 2(λmax{ΘᵀΘ}
+λmax{ΓAAᵀΓ})‖zk − zk+1‖2M
= 0;
(4.21)
The relation (4.9c) ensures that we always have
‖∇˜f(yk+1)− Γᵀqk+1‖2Fro = 0 (4.22)
By comparing (4.19)–(4.22) with the first-order optimality condition (4.7), we can
see that the limit point z∞ satisfies the KKT system (4.7) thus is an optimal solution
to the KKT system. Finally, we conclude that all blocks of x∞ are equal to each
other and every block of x∞ is an optimal solution to problem (4.5) (x part). This
concludes the proof.
In addition to the infinite summability of {‖zk − zk+1‖2M} shown above, in the
following Lemma 2, we will show that this sequence is also monotonic non-increasing.
Lemma 2 (Monotonic successive difference). Under the same settings as those in
Theorem 1, the sequence {zk} generated by the proposed algorithm satisfies
‖zk+1 − zk+2‖2M ≤ ‖zk − zk+1‖2M, (4.23)
for any k = 0, 1, . . ..
Proof. To ease the description of the proof, let us define ∆xk+1 , xk−xk+1, ∆rk+1 ,
rk− rk+1, ∆yk+1 , yk−yk+1, ∆qk+1 , qk−qk+1, ∆zk+1 , zk− zk+1, ∆∇˜g(xk+1) ,
∇˜g(xk)− ∇˜g(xk+1), and ∆∇˜f(yk+1) , ∇˜f(yk)− ∇˜f(yk+1).
By the convexity of ∇˜g, we have
0 ≤ 2〈∆xk+1,∆∇˜g(xk+1)〉. (4.24)
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Taking the the successive difference of (4.9a) gives
(Θ−AᵀΓᵀΓA−  L)(∆xk+1 −∆xk)
+AᵀΓᵀΓ(∆yk+1 −∆yk)
= −∆∇˜g(xk+1)−U∆rk+1 −AᵀΓᵀ∆qk+1.
(4.25)
Substituting (4.25) into the second term of the right-hand-side of (4.24) for ∆∇˜g(xk+1)
yields
0
≤ 2〈∆xk+1,−(Θ−AᵀΓᵀΓA−  L)(∆xk+1 −∆xk)〉
+2〈∆xk+1,−AᵀΓᵀΓ(∆yk+1 −∆yk)〉
+2〈U∆xk+1,−∆rk+1〉+ 2〈∆xk+1,−AᵀΓᵀ∆qk+1〉.
(4.26)
Next, let us look into the four terms at the right-hand-side of (4.26). The first term
has an appropriate form; For the second term, we have
2〈∆xk+1,−AᵀΓᵀΓ(∆yk+1 −∆yk)〉 (by (4.8c))
= 2〈Γ∆yk+1 + ∆qk+1 −∆qk,−Γ(∆yk+1 −∆yk)〉
= 2〈∆yk+1,−ΓᵀΓ(∆yk+1 −∆yk)〉
−2〈∆qk+1 −∆qk,Γ(∆yk+1 −∆yk)〉.
(4.27)
For the third term, by (4.9f), we have
2〈U∆xk+1,−∆rk+1〉 = 2〈∆rk+1 −∆rk,−∆rk+1〉. (4.28)
For the last term, we have
2〈∆xk+1,−AᵀΓᵀ∆qk+1〉 (by (4.8c))
= 2〈Γ∆yk+1 + ∆qk+1 −∆qk,−∆qk+1〉 (by (4.9c))
= −2〈yk − yk+1, ∇˜f(yk)− ∇˜f(yk+1)〉
+2〈∆qk+1 −∆qk,−∆qk+1〉 (by the convexity of f)
≤ 2〈∆qk+1 −∆qk,−∆qk+1〉.
(4.29)
Combining (4.26)–(4.29) gives
0 ≤ 2〈∆xk+1,−(Θ−AᵀΓᵀΓA−  L)(∆xk+1 −∆xk)〉
+2〈∆yk+1,−ΓᵀΓ(∆yk+1 −∆yk)〉
−2〈∆qk+1 −∆qk,Γ(∆yk+1 −∆yk)〉
+2〈∆rk+1 −∆rk,−∆rk+1〉
+2〈∆qk+1 −∆qk,−∆qk+1〉
= 2〈∆zk −∆zk+1,M∆zk+1〉
−2〈∆qk+1 −∆qk,Γ(∆yk+1 −∆yk)〉
= ‖∆zk‖2M − ‖∆zk+1‖2M − ‖∆zk −∆zk+1‖2M−2〈∆qk+1 −∆qk,∆yk+1 −∆yk〉,
(4.30)
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and thus we eventually have
‖∆zk‖2M − ‖∆zk+1‖2M≥ ‖∆zk −∆zk+1‖2M
+2〈∆qk+1 −∆qk,Γ(∆yk+1 −∆yk)〉
= ‖∆xk −∆xk+1‖2Θ−AᵀΓᵀΓA− L + ‖∆rk −∆rk+1‖2Fro
+‖(∆qk+1 −∆qk) + Γ(∆yk+1 −∆yk)‖2Fro≥ 0,
(4.31)
which completes the proof.
We will use Theorem 1 and Lemma 2 to establish the rate of convergence. Before
that, we need an interlude on the convergence property of a nonnegative monotonic
scalar sequence. This is stated as a proposition bellow which has also appeared in
recent works [Deng et al., 2017,Davis and Yin, 2017,Shi et al., 2015b].
Proposition 1. If a sequence {ak} ⊂ R is: (i) nonnegative, ak ≥ 0, (ii) summable,∑∞
t=1 at < ∞, and (iii) monotonically non-increasing, ak+1 ≤ ak, then we have:
ak = o(1/k).
Proof. Since ak is monotonically non-increasing, we have ka2k ≤
∑2k
t=k+1 at. By this,
along with the fact that limk→∞
∑2k
t=k+1 at → 0 which is given by the summability,
we get ak = o(1/k).
Theorem 2 (Sublinear rate). Under the same settings as those in Theorem 1, the
first-order optimality residuals (violation to the KKT system (4.7)):
(i) Consensus violation ‖Uxk‖2Fro;
(ii) Local replication error ‖Γ(Axk − yk)‖2Fro;
(iii) Dual/Gradient span space error ‖∇˜g(xk) + Urk + Aᵀ∇˜f(yk)‖2Fro
all converge at an o(1/k) rate.
Proof. By applying Proposition 1 to the results of Theorem 1 and Lemma 2, we have
that ‖zk − zk+1‖2M = o(1/k). By using the definition of z and the recursive relation
for zk+1 of the Algorithm 1, we derive the statement of this theorem.
Remark 1 (Fully localized parameter settings). We have obtained that under the
parameter settings Θ−AᵀΓᵀΓA−  L  0, the algorithm converges at an o(1/k) rate.
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Here we show that the parameter selection can be fully localized. As presented in
Section 4.1, we choose  L = (Im−W)⊗ Id+1 where W is an m×m doubly stochastic
matrix whose non-zero pattern meets the topology of the underlying communication
network. The agents in the network can determine/implement a W matrix only
using local information in a purely decentralized manner. Such matrix W satisfies
−Im ≺W 4 Im thus 0 4  L ≺ 2Im(d+1). To fulfill Θ−AᵀΓᵀΓA−  L  0, we only need
Θ−AᵀΓᵀΓA  2Im(d+1), which can be broken down to Θj−AᵀjΓᵀjΓjAj  2Id+1, ∀j.
Each agent j has the freedom of how it would like to choose its own Θj and Γj to
satisfy such requirement. We recommend that one chooses Γj to make the largest and
smallest nonzero eigenvalues of AᵀjΓ
ᵀ
jΓjAj close to 2 and then Θ can be chosen as
4Im(d+1).
4.2 Application of cPDS on `1-Regularized Support Vector
Machines
In this section we will apply cPDS to the large-scale distributed sSVM problem.
Assume that n samples of data (patients EHRs) are distributed among m agents
(hospitals) that want to collectively agree on a global classifier to separate the two
classes. Each agent is holding nj samples and maintains a copy (βj, βj0) of the
classifier parameters to be estimated. (βj, βj0) are updated in each iteration of the
method, using data locally stored in the agent as well as information that the agent
receives from its neighbors. Let φji ∈ Rd and lji ∈ R be the features and the label
of sample i in agent j accordingly and fji be the corresponding hinge loss for that
sample. gj contains the regularizers of parameters (βj, βj0) for each agent j. Define
aji = (ljiφji, lji), which we will use later. In every iteration each agent updates
xj = (βj, βj0) ∈ Rd+1, yj ∈ Rnj , qj ∈ Rnj and λj ∈ Rd+1. Let us illustrate below the
cPDS updates that each agent is performing. For simplicity in the implementation,
we use Θj = θjId+1, where θj is a positive scalar maintained by agent j locally. Next
we describe the updates over each agent j.
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x-update
(βk+1j , β
k+1
j0 ) = arg min
βj ,β0j
nj∑
i=1
γji(2q
k
ji − qk−1ji )aᵀji(βj, βj0)
+
τ
2
‖βj‖2 + ρ‖βj‖1 + (2λkj − λk−1j )ᵀ(βj, βj0) + 0.5‖(βj, βj0)− (βkj , βkj0)‖2θj
(4.32)
The simple form of the non-smooth gj allows us to get a closed form solution for this
problem. Problem (4.32) can be decoupled into two problems, one that finds βk+1j ,
whose solution is given by the soft thresholding function, i.e., ∀ t = 1, . . . , d,
β∗jt = sgn(ujt)(|ujt| − µ)+ =

ujt − µ, if ujt > µ,
0, if |ujt| ≤ µ,
ujt + µ, if ujt < −µ,
with µ = (2ρ)/(τ + θj) and uj = −1/(τ + θj)
[
nj∑
i=1
γjilji(2q
k
ji − qk−1ji
)
φji + (2λ
k
j,1:d −
λk−1j,1:d)− θjβkj
]
, and one that finds βk+1j0 , which has as an optimal solution:
β∗j0 =
−
nj∑
i=1
γjilji(2q
k
ji−qk−1ji )−(2λki,d+1−λk−1i,d+1)+θjβkj0
θj
(4.33)
y-update
yk+1j = arg min
yj
nj∑
i=1
{
max{0, 1− yji} − γjiqkjiyji
+
1
2
‖γji(ljiφᵀjiβk+1j + ljiβk+1j0 − yji)‖2
}
.
(4.34)
To deal with the second non-smooth term, the hinge loss function, we consider
three cases for each term: 1− yji > 0, 1− yji < 0 and 1− yji = 0. For each agent j,
we can obtain every entry of yj in parallel, i.e., for all i:
• Solve y˜k+1ji = arg min
yji
{
(γ2jiy
2
ji)/2 + (−1− γjiqkji − γ2jiljiφᵀjiβk+1j − γ2jiljiβk+1j0 )
}
,
which yields y˜k+1ji = 1/γ
2
ji
(
1 + γjiq
k
ji + γ
2
jiljiφ
ᵀ
jiβ
k+1
j + γ
2
jiljiβ
k+1
j0
)
. If 1− y˜ji > 0,
then yk+1ji = y˜
k+1
ji ; otherwise proceed to the next step.
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• Solve y˜k+1ji = arg min
yji
{γjiqkji,−yji + 1/2‖γji(ljiφᵀjiβk+1j + ljiβk+1j0 − yji)‖2}, which
yields y˜ji = 1/γ
2
ji
(
γjiq
k
ji + γ
2
jiljiφ
ᵀ
jiβ
k+1
j + γ
2
jiljiβ
k+1
j0
)
. If 1 − y˜k+1ji < 0, then
yk+1ji = y˜
k+1
ji ; otherwise proceed to the next step.
• yk+1ji = 1.
q-update ∀i
qk+1ji = q
k
ji + γji(ljiφ
ᵀ
jiβ
k+1
j + ljiβ
k+1
j0 − yk+1ji ) (4.35)
λ-update
λk+1j = λ
k
j +
∑
i∈Nj∪{j}
wjix
k+1
j (4.36)
Last, let us mention that the storage needed to operate cPDS for sSVM following
the updates in this section is O(nd), which is the same as the other methods listed
in Table 4.1 (also see Table 4.1 for other comparisons).
4.3 Experimental Results on the Heart Disease Dataset
We will now apply our methodology to solve the heart diseases hospitalization predic-
tion problem. We measure the performance of cPDS in terms of the Area Under the
Receiver Operator Characteristic (ROC) curve (AUC), which plots the detection rate
(i.e., out of the hospitalized patients how many were correctly predicted as hospital-
ized) versus the false alarm rate (i.e., out of the non-hospitalized patients how many
were wrongly predicted to be hospitalized). We also consider for comparison the bar-
rier method, the SubGD, the IncrSub descent and the LAC scheme we have mentioned
in the Introduction. For SubGD and IncrSub, we use the steplength rule for the di-
minishing stepsize.7 The parameters for all methods are selected via cross-validation.
7Following the steplength rule, the diminishing stepsize in k-th iteration is set as ak =
a0/(‖∇˜g(xk)‖+ ), where a0 is an initial value of the stepsize and  a very small number.
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In cPDS the data are distributed between m = 10 hospitals connected through a
random graph generated by the Erdo˝s–Re´nyi model. Using this model, a graph is
constructed by connecting nodes randomly. Each edge is included in the graph with
probability p independent from every other edge. In our experiments, we have used
p = 0.2. Table 4.2 shows the AUC and the total running time of the algorithms
to perform the maximum number of iterations reported. In the experiment, cPDS
gives a comparable AUC as IncrSub does, both outperforming the others. Although
cPDS requires more time than IncrSub does, it can work over general decentralized
networks.
Table 4.2: Numerical performance of different methods for solving the
sSVM problem: AUC, maximum number of iterations, total running
time (in secs).
Method Distributed? AUC max iters total time
SubGD × 0.7667 1500 2055
Barrier × 0.7688 32 40.174
IncrSub × 0.7734 554 6.3485
LAC
√
0.7520 1000 147, 090
cPDS
√
0.7711 2000 11, 176
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Chapter 5
An Alternating Clustering and
Classification Framework
We seek to predict hospitalizations associated with heart diseases or diabetes within
one year from the time the EHR of a patient is examined. We treat hospitalization
prediction as a classification problem, distinguishing between patients likely to be hos-
pitalized or not. Intuitively, however, patients belong to different clusters depending
on their demographics and ailments that are likely to cause a future hospitalization.
The supervised learning methods we have explored so far can certainly make classi-
fications without considering these hidden clusters; yet, identifying the clusters can
potentially improve classification performance. An additional key benefit of hidden
cluster identification is that results become more interpretable. Patients in the same
cluster, especially if the cluster is identified based on a low-dimensional subspace of
“diagnostic” features, share key characteristics and their cluster membership offers
an explanation as to why they have been flagged for a future hospitalization. In the
medical setting, interpretability has an essential role in persuading physicians to trust
the learning outputs and rely on them for their decision making. EHRs exhibit inter-
esting special structure in that for each patient only a very low-dimensional subset of
features is important in predicting a future hospitalization. This subset is different
for each cluster and, typically, there is no universal set of irrelevant features that can
be eliminated. This suggests that it is useful to consider sparse classifiers for each
cluster.
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Related literature: In the literature, there are generally two types of assump-
tions about hidden clusters in a classification problem, implicit or explicit. The im-
plicit approach is more prevalent, which is implied in piecewise linear techniques [Tou-
ssaint and Vijayakumar, 2005, Dai et al., 2006, Yujian et al., 2011, Pele et al., 2013].
The purpose of a piecewise linear classifier is to approximate nonlinear boundaries
with a union of local linear classifiers. Therefore samples are implicitly assumed to
lie in local regions/clusters and classified by the local classifiers there. A more ob-
vious assumption of hidden clusters (even though still implicit) is in feature space
partitioning methods. Tree-based methods [Breiman et al., 1984] partition the whole
feature space into sub-regions and each sub-region can be viewed as a cluster. Differ-
ent from the greedy approach tree methods took, [Wang and Saligrama, 2012] utilize
an iterative way of partitioning the feature space and train classifiers inside each sub-
region. All these methods do not have clustering as their goal and clusters are simply
a byproduct in their classification models.
An explicit assumption of clusters within a classification problem is proposed
in [He et al., 2006,Gu and Han, 2013], where training samples are first put into clusters
and then separate classifiers are trained. They both do clustering once and [He et al.,
2006] trains classifiers in parallel while [Gu and Han, 2013] trains classifiers jointly.
Due to the sequential procedure, the clustering does not take label information into
account and thus these methods’ advantage mostly lie in boosting the speed of model
training.
A special feature of our problem is that the two classes are asymmetric in the
sense that only the positive samples are assumed to have hidden clusters. A concrete
example can be drawn again from medical diagnosis, where the positive class repre-
sents the unhealthy people and the negative class represents the opposite. It is very
intuitive that people get sick for various reasons (viewed as different clusters) while
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the healthy people should be healthy in every aspect (thus forming only one cluster).
A similar asymmetric setting is also proposed in [Zhao and Shrivastava, 2013] where
the data are assumed to be imbalanced and the larger class contains hidden clusters.
Their solution is to solely cluster the larger class and train classifiers with copies of
the samples from the other class. We design two methods along this direction which
serve as our baseline for comparison.
From all the related literature, the most similar problem is mentioned in [Fil-
ipovych et al., 2012], also with a medical application. There, they try to maximize
the margin between hidden clusters and, thus, are generally suitable for cases with
only two hidden clusters. Besides, they use mixed integer programming to represent
the cluster tags, which makes the problem intractable for large instances.
5.1 Problem Definition
We consider a classification problem that has multiple hidden clusters in the positive
class, while the negative class is assumed to be drawn from a single distribution. For
different clusters in the positive class, we assume that the discriminative dimensions,
with respect to the negative class, are different and sparse. We could think of these
clusters as “local opponents” to the whole negative set (see Fig. 5·1) and therefore,
the “local boundary” (classifier) could naturally be assumed to be different and lying
in a lower-dimensional subspace of the feature vector.
In summary, the classification problem satisfies the following assumptions:
• The negative class samples are assumed to be i.i.d. and drawn from a single
cluster with distribution P0.
• The positive class samples belong to L clusters, with distributions P 11 , · · · , PL1 .
• Different positive clusters have different features that separate them from the
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negative samples.
y = +1 
y =  -1 
Figure 5·1: Positive clusters as “local opponents”. The positive class
contains two clusters and each cluster is linearly separable from the
negative class, denoted by dashed lines.
We propose a joint cluster detection and classification problem under the SVM
framework. Let (x+i , y
+
i ) and (x
−
j , y
−
j ) be the D+1 dimensional positive and negative
samples, where i ∈ {1, 2, . . . , N+} and j ∈ {1, 2, . . . , N−}. Let T be the parameter
controlling the local sparsity. Assuming L hidden clusters in the positive class, we
try to discover the L hidden clusters (denoted by a mapping function l(i)) and L
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classifiers (βl, βl0’s, one for each cluster) as the solution of
min
βl,βl0,l(i)
L∑
l=1
(
1
2
||βl||2 + λ+ ∑
i:l(i)=l
ξ
l(i)
i + λ
−
N−∑
j=1
ζ lj
)
s.t.
D∑
d=1
|βld| ≤ T,
ξ
l(i)
i ≥ 1− y+i βl(i)0 −
D∑
d=1
y+i β
l(i)
d x
+
i,d,
ζ li ≥ 1− y−j βl0 −
D∑
d=1
y−j β
l
dx
−
j,d,
ξ
l(i)
i , ζ
l
j ≥ 0,
where y+i = 1, and y
−
j = −1.
(5.1)
The negative samples are not clustered but simply copied into each cluster. So
their empirical costs are counted L times as shown in (5.1). The relative weight of
costs from negative samples compared to that of the positive samples is controlled by
λ− and λ+. The constraint
D∑
d=1
|βld| ≤ T is an `1-relaxation of the sparsity requirement
to the local classifiers.
5.2 Alternating Clustering and Classification (ACC)
Problem (5.1) involves two sets of decision variables: (βl, βl0) for the classifiers and
l(i) for cluster assignment. The problem is a mixed integer programming problem,
but given l(i), it reduces to L quadratic optimization problems. This motivates
the alternating clustering and classification (ACC) optimization approach we present
next.
The process starts with a random cluster assignment of the positive clusters and
then alternates between two modules: (i) training a classifier for each cluster and (ii)
re-clustering samples given all the estimated classifiers using a subset of “diagnostic”
features C. Note that since only positive samples belong to different clusters, only
these samples need to be re-clustered. During the training phase, we alternate be-
tween (i) –training L sparse classifiers– and (ii) –re-clustering the positive samples
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given the classifiers– until convergence. Algorithm 2 describes the training process,
while Algorithm 3 provides details on how we re-cluster the positive samples given
the classifiers learnt in (i).
The re-clustering step concentrates only on a subset of “discriminative” features
C ⊆ {1, 2, . . . , D}, which adds more flexibility to the model and allows us to incor-
porate prior knowledge, so that the discovered clusters are more intuitive. Also note
that the re-clustering step in ACC does not need to assume any cluster centers, as is
common in other clustering methods (e.g., in k-means [Lloyd, 1982]). The reason is
that samples labels are available during training (in contrast with a typical cluster-
ing problem) and the goal of clustering is to assist classification. Samples are being
assigned into a cluster, where they lie as far away as possible from the classification
boundary, i.e., the projection < xi,C,β
l
C > is the maximum. When checking for the
maximum projection, an extra constraint (5.3) needs to be imposed to guarantee
the global convergence of the alternating optimization process. Intuitively, the terms
in (5.3) are associated with the slack variables in the sparse linear SVM (SLSVM)
problem, as presented in (5.9), and imposing this constraint will guarantee that the
alternating process moves in a monotonic direction, such that the costs from the slack
variables are non-increasing.
Ol = min
βl,βl0
1
2
||βl||2 + λ+
N+l∑
i=1
ξli + λ
−
N−l∑
j=1
ζ lj
s.t.
D∑
d=1
|βld| ≤ T,
ξli, ζ
l
j ≥ 0,
ξli ≥ 1− y+i βl0 −
D∑
d=1
y+i β
l
dx
+
i,d,
ζ li ≥ 1− y−j βl0 −
D∑
d=1
y−j β
l
dx
−
j,d,
where y+i = 1, ∀i ∈ {1, . . . , N+l } and
y−j = −1 ∀j ∈ {1, . . . , N−l }.
(5.2)
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Algorithm 2 Alternating Clustering and Classification Training
Initialization:
Randomly assign positive class sample i to cluster l(i). i ∈ {1, . . . , N+} and l(i) ∈
{1, . . . , L}.
repeat
Classification Step:
Train an SLSVM classifier for each cluster of positive samples combined with
all negative samples. Each classifier is the outcome of a quadratic optimization
problem (5.9), that provides βl and Ol.
Re-clustering Step:
Re-cluster the positive samples based on the classifiers βl and update l(i)’s.
until no l(i) is changed or
∑
lO
l (the sum of the objective values in training
classifiers) is not decreasing.
Once training has been performed with Algorithm 2, we can classify a newly pre-
sented sample not seen during training using Algorithm 4. Specifically, we compute
the projections on each classifier and assign the new sample to the cluster with the
largest projection value. We use the classifier of this cluster to classify the corre-
sponding samples. We note that tuning λ+ and λ− in ACC should be done globally,
i.e., λ+ and λ− should be fixed across all clusters to guarantee convergence.
Two Hierarchical Methods for Clustering and Classification. To demon-
strate the superiority of ACC, we will compare it against regural SVM that use a
linear or an RBF kernel and with other binary supervised learning methods, such
as `1-regularized logistic regression and random forests [Friedman et al., 2001]. We
will also compare ACC with two hierarchical methods which naturally arise from our
assumptions regarding the data.
Since we assume that only the positive class contains clusters, during the model
training phase we could first cluster the positive samples (still based on the feature
set C ), then copy negative samples into each cluster, and finally optimize classifiers
(linear SVMs) for each cluster. For clustering we adopt the widely used k-means
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Algorithm 3 Re-clustering procedure given classifiers
Input: positive samples x+i , classifiers β
l, current cluster assignments which as-
signs sample i to cluster l(i).
for all i ∈ {1, . . . , N+} do
for all l ∈ {1, . . . , L} do
calculate projection ali from positive sample i onto the classifier for cluster l
with only desired dimensions C. ali =< x+i,C,βlC > ;
end for
update cluster assignment of sample i from l(i) to
l∗(i) = arg max
l
ali,
subject to
< x+i ,β
l∗(i) > +β
l∗(i)
0 ≥ < x+i ,βl(i) > +βl(i)0 . (5.3)
end for
Algorithm 4 Alternating Clustering and Classification Testing
for each test sample x do
Assign it to cluster l∗ = arg max
l
< xC,β
l
C >.
Classify x with βl
∗
.
end for
method [Lloyd, 1982]. To classify new (test) samples we can use an approach just like
the ACC method. We name this algorithm Cluster Then Linear SVM (CT-LSVM).
The second hierarchical method we introduce is very similar to CT-LSVM but
instead of training a linear SVM, we train a sparse linear SVM, calling this method
Cluster-Then- Sparse-Linear-SVM (CT-SLSVM). Notice that an important difference
between CT-LSVM, CT-SLSVM and ACC is that ACC has an alternating procedure
while the other two do not. With only one-time clustering, CT-LSVM and CT-
SLSVM create unsupervised clusters without making use of the negative samples,
whereas ACC is taking class information and classifiers under consideration so that
the clusters also help the classification.
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5.3 ACC Theoretical Performance Guarantees
We begin by presenting a result that suggests a favorable sample complexity for
SLSVM compared to the standard linear SVM. Suppose that SLSVM for the l-th
cluster yields Ql < D non-zero elements of βl, thus, identifying a Ql-dimensional
feature subspace used for classification. The value of Ql is controlled by T l. Assume
we draw a training set with N− negative samples from P0 and N+l positive samples
from P l1, where N
l = N+l +N
−. Let RlN denote the expected training error rate and
Rl the expected test error under these distributions.
Theorem 3. For a sparse linear SVM lying in a Q-dimensional subspace of the
original D-dimensional space, for any  > 0 and δ ∈ (0, 1), if the sample size N l
satisfies
N l ≥ 8
2
(
(Ql + 1)log
2eN l
Ql + 1
+Qllog
eD
Ql
+ log
2
δ
)
, (5.4)
then with probability no smaller than 1− δ, Rl −RlN ≤ .
Proof. To simplify notation we drop the cluster index l. We will use a result from [Bous-
quet et al., 2004]. We note that the family of linear classifiers in a D-dimensional
space has VC-dimension D + 1 ( [Vapnik, 1998]). Let G be a function family with
VC-dimension D + 1. For ease of notation we will drop the reference to the l-th
cluster as the result applies to all clusters. Let RN(g) denote the training error rate
of classifier g on N training samples randomly drawn from an underlying distribution
P . Let R(g) denote the expected test error of g with respect to P . The following
theorem from [Bousquet et al., 2004] is useful in establishing our result.
Theorem 4 ( [Bousquet et al., 2004]). If the function family G has VC-dimension
D + 1, then
P
R(g)−RN (g) ≤ 2
√
2
(D + 1) log 2eND+1 + log
2
ρ
N
 ≥ 1− ρ (5.5)
for any function g ∈ G and ρ ∈ (0, 1).
For the given  select large enough N such that
 ≥ 2
√
2((D + 1) log(2eN/D + 1) + log(2/ρ))/N.
68
or
2/ρ ≤ exp{(N2)/8− (D + 1) log(2eN/(D + 1))} . (5.6)
It follows from Theorem 4
P (R(g)−RN(g) ≥ ) ≤ ρ. (5.7)
In our setting, the classifier g is restricted to a Q-dimensional feature subspace of the
D-dimensional feature space. Thus, the bound in (5.6) holds by replacing D with Q
in the right hand side and the bound in 5.7 holds for any such Q-dimensional subspace
selected by the `1-penalized optimization. Since there are
(
D
Q
)
possible choices for the
subspace, using the union bound and the inequality
(
D
Q
) ≤ ( eD
Q
)Q = exp(Q log eD
Q
),
we obtain:
P (R(g)−RN(g) ≥ ) ≤ ρ exp
{
Q log
eD
Q
}
(5.8)
For the given δ ∈ (0, 1) in the statement of Theorem 3, select small enough ρ such
that
δ ≥ ρ exp
{
Q log
eD
Q
}
or equivalently
1
δ
≥ 1
ρ
exp
{
−Q log eD
Q
}
Using 5.6 (with Q replacing D), we obtain
log
2
δ
≤ N
2
8
− (Q+ 1)log 2eN
Q+ 1
−QlogeD
Q
which implies that N must be large enough to satisfy
N ≥ 8
2
(
(Q+ 1)log
2eN
Q+ 1
+Qlog
eD
Q
+ log
2
δ
)
This establishes P (R(g)−RN(g) ≥ ) ≤ ρ, which is equivalent to Theorem 3 and
concludes the proof.
Theorem 5. The ACC algorithm converges for any set C.
Proof. At each alternating cycle, for each cluster l we train a SLSVM with positive
samples of that cluster combined with all negative samples. This produces an optimal
69
value Ol and the corresponding classifier (βl, βl0). Specifically, the formulation is:
Ol = min
βl,βl0,
ζlj ,ξ
l
i
1
2
||βl||2 + λ+
N+l∑
i=1
ξli + λ
−
N−∑
j=1
ζ lj (5.9)
s.t. ξli ≥ 1− y+i βl0 −
∑D
d=1 y
+
i β
l
dx
+
i,d, ∀i;
ζ lj ≥ 1− y−j βl0 −
∑D
d=1 y
−
j β
l
dx
−
j,d, ∀j;∑D
d=1 |βld| ≤ T l; ξli, ζ lj ≥ 0, ∀i, j.
We use the sum of the optimal objective function values in (5.9) across different
clusters to prove the convergence. We have
Z =
L∑
l=1
Ol =
L∑
l=1
(
1
2
||βl||2 + λ−
N−∑
j=1
ζ lj
)
+ λ+
N+∑
i=1
ξ
l(i)
i ,
where l(i) maps sample i to cluster l(i),
∑L
l=1N
+
l = N
+, and βl, βl0, ζ
l
j, and ξ
l(i)
i are
optimal solutions of (5.9) for each l. Now, let us consider the change of Z at each
iteration of the ACC procedure.
First, we consider the re-clustering step given SLSVMs. During the re-clustering
step, the classifier and slack variables for negative samples are not modified. Only
the ξ
l(i)
i get modified since the assignment functions l(i) change. When we switch
positive sample i from cluster l(i) to l∗(i), we can simply assign value ξl(i)i to ξ
l∗(i)
i .
Therefore, the value of Z does not change during the re-clustering phase and takes
the form
Z =
L∑
l=1
(
1
2
||βl||2 + λ+
∑
{i:l∗(i)=l}
ξli + λ
−
N−∑
j=1
ζ lj
)
.
Next, given new cluster assignments we re-train the local classifiers by resolving
problem (5.9) for each cluster l. Notice that re-clustering was done subject to the
constraint in Eq. (5.3) (see Alg. 3). Since y+i = 1, we have
ξ
l(i)
i ≥ 1− βl(i)0 −
D∑
d=1
β
l(i)
d x
+
i,d ≥ 1− βl
∗(i)
0 −
D∑
d=1
β
l∗(i)
d x
+
i,d.
The first inequality is due to ξ
l(i)
i being feasible for (5.9). The second inequality is
due to y+i = 1 and Eq. (5.3) in Alg. 3. Thus, by assigning ξ
l(i)
i to ξ
l∗(i)
i it follows
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that the ξ
l∗(i)
i remain feasible for problem (5.9). Given that the remaining decision
variables do not change, (βl, βl0, ζ
l
j, ξ
l∗(i)
i , ∀i = 1, . . . , N+l , ∀j = 1, . . . , N−) forms a
feasible solution of problem (5.9). This solution has a cost equal to Ol. Re-optimizing
can produce an optimal value that is no worse. It follows that in every iteration of
ACC, Z is monotonically non-increasing. Given that Z is bounded below by zero, we
establish the convergence of ACC.
As a remark on convergence, it is worth mentioning that the values λ+ and λ−
should be fixed across all clusters to guarantee convergence.
Let H denote the family of clustering/classification functions produced by ACC.
Theorem 6. The VC-dimension of H is bounded by
VACC , (L+ 1)L(D + 1) log
(
e
(L+ 1)L
2
)
. (5.10)
Proof. The proof is based on Lemma 2 of [Sontag, 1998]. Given the L functions
for clustering, named g1, g2, . . . , gL, the final cluster of a sample is determined by
the maximum of g1 to gL. This clustering process could be viewed as the output of
(L−1)L/2 comparisons between pairs of gi and gj, where 1 ≤ i < j ≤ L. The pairwise
comparison could be further transformed into a boolean function (i.e., sign(gi − gj)).
Then together with the L classifiers for each cluster, we have a total of (L + 1)L/2
boolean functions to make the final classification. Among all these boolean functions,
the maximum VC-dimension is D + 1.
From Theorem 6, we draw the observation that the VC-dimension of ACC grows
linearly with the dimension of data samples and polynomially (between quadratic
and cubic) with the number of clusters. Since the local classifier is trained under
an `1 constraint, it is defined in a lower dimensional subspace. At the same time,
the clustering function also lies in a lower dimensional space C. Thus, the bound in
Theorem 6 could be tighter in practice.
An immediate consequence of Theorem 6 is the following corollary which estab-
lishes out-of-sample generalization guarantees for ACC-based classification and is
based on a result in [Bousquet et al., 2004].
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Corollary 1. For any ρ ∈ (0, 1), with probability at least 1− ρ it holds:
R ≤ RN + 2
√
2
VACC log
2eN
VACC
+ log 2
ρ
N
5.4 Experimental Results on the Heart Disease Dataset
For ACC, parameter tuning was done by 3-fold cross-validation with only training
data. Some preliminary experiments led us to set T l = 6. L explicitly varies in
(2, 3, 4, 5, 6) for all methods involving clustering. ACC uses a subset of “diagnostic”
features for clustering to better delineate across various types of heart disease. We
use the Area Under the ROC Curve (AUC) again as the performance criterion. In
Table 5.1, only the best results for CT-LSVM and CT-SLSVM are presented (L = 2).
The last column of Table 5.1 counts the number of times (out of 10 runs) that each
method’s AUC outperforms RBF SVM. It can be seen from the table that ACC
outperforms the alternatives by anywhere between 0.97% and 5.75% in average AUC.
Under L = 3, ACC outperforms RBF SVM in 10 our of 10 repetitions.
Settings avg. AUC std. AUC #
ACC, L = 2 76.83% 0.87% 10
ACC, L = 3 77.06% 1.04% 10
ACC, L = 4 75.14% 0.92% 10
ACC, L = 5 75.14% 1.00% 9
ACC, L = 6 74.32% 0.87% 6
Lin. SVM 72.83% 0.51% 3
RBF SVM 73.35% 1.07% -
CT-LSVM (L = 2) 71.31% 0.76% 0
CT-SLSVM (L = 2) 71.97% 0.73% 1
Table 5.1: Average (avg) and standard deviation (std) of the Prediction
Accuracy (AUC) of various methods on Heart Disease Data.
To interpret the clusters generated by ACC, we plot in Figure 5·2 the mean value
over each cluster of each element in the feature vector xC. The 3 clusters are well-
separated. Cluster 2 contains patients with other forms of chronic ischemic disease
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(mainly coronary atherosclerosis) and old myocardial infarction. Cluster 3 contains
patients with dysrhythmias and heart failure. Cardiologists would agree that these
clusters contain patients with very different types of heart disease. Finally, Cluster 1
contains all other cases with some peaks corresponding to endocardium/pericardium
disease.
Figure 5·2: Average feature values in each cluster (L = 3) for the
heart diseases dataset.
5.5 Experimental Results on the Diabetes Dataset
Figure 2 plots ROC curves for a variety of classification methods and Table III lists
the corresponding AUCs (average and standard deviation of AUC over 10 runs with
different training and test sets). Parameter tuning was done for all methods using
k-fold cross validation. For ACC, the initial assignment of the positive samples to the
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clusters is random. The parameters as used in 5.1 are set as follows. Some preliminary
experiments led us to set the sparsity-controlling parameter T l to 8. The number
of clusters L explicitly takes its values from {2, 3, 4, 5, 6} for all methods involving
clustering, the soft-margin parameter for the negative class λ− takes its values from
{100, 10, 1, 0.1} and the soft-margin parameter for the positive class λ+ is set equal to
Lλ−. For all methods 40% of the data are used for training and the rest for testing.
The training data are normalized to have zero mean and unit standard deviation and
are balanced by down-sampling the negative population. We also compare ACC with
CT-LSVM and CT-SLSVM. Only the best results for CT-LSVM (obtained under
L = 2) and CT-SLSVM (obtained under L = 2) are presented.
Clustering with ACC can use a subset of “diagnostic” features (subset C), since
these are the features that better delineate across different types of diabetes compli-
cations. We base, however, the clustering in these experiments on all features due to
the fact that almost all triplet features are related to “diagnostic” features. In Table
5.2, random forests perform best, perhaps not surprisingly since they produce very
complex classifiers. Still, and most importantly, they lack interpretability, because
of the complexity of the models they produce. ACC performs the best among the
remaining alternative methods, and is able to detect the hidden positive clusters and
identify why a specific patient is labeled as hospitalized. It is interesting that ACC
performs quite well even though the resulting classifiers are relatively sparse and do
not use many features. This also makes them easy to implement. Notice that ACC
utilizes sparse linear SVM as the base classifier. According to Theorem 4, sparsity
(i.e., small D) leads to smaller generalization error. ACC also proved to be efficient
from a computational point of view, since in our implementation, it is faster than
random forests by a factor of 3.
In an attempt to interpret the ACC clusters we plot in Figure 3 the mean value
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Settings avg. AUC std. AUC
ACC, L = 1 (SLSVM) 0.7924 0.0052
ACC, L = 2 0.7855 0.0041
ACC, L = 3 0.7853 0.0041
ACC, L = 4 0.7846 0.0035
ACC, L = 5 0.7836 0.0036
ACC, L = 6 0.7818 0.0050
Lin. SVM 0.7687 0.0048
RBF SVM 0.7796 0.0027
CT-LSVM (L = 2) 0.7563 0.0050
CT-SLSVM (L = 2) 0.7799 0.0049
sparse logistic regression 0.7891 0.0038
random forests 0.8454 0.0026
Table 5.2: Average (avg) and standard deviation (std) of the Prediction
Accuracy (AUC) of various methods on Diabetes Data.
over each cluster of each element in the feature vector, using as diagnostic features
the subset of features which have a correlation larger than 0.01 with the labels in
the training set. This is done for a single repetition of the experiment and L = 3,
yielding interesting clusters and highlighting the interpretative power of ACC. We
observe that Cluster 1 contains diabetes patients with chronic skin ulcers, hyperten-
sion, and an abnormal glucose tolerance test. Cluster 2 contains patients with more
severe complications including cerebrovascular disease, hypertension, and heart dis-
eases. Cluster 3 contains patients with less acute disease, combining diabetes with
hypertension. The feature values of these three clusters clearly separate from the
feature values in the negative class.
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Figure 5·3: Average feature values in each cluster (L = 3) for the
diabetes dataset.
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Chapter 6
Conclusions
6.1 Key Findings
In this thesis, we studied and developed a variety of centralized and distributed meth-
ods for predictive health analytics and we showcased them for the novel, to the best
of our knowledge, problem of predicting heart- and diabetes- related hospitalizations
based on patients Electronic Health Records (EHRs). Below, we summarize our
methods and key findings, in the order they were presented:
• We explored a variety of supervised classification methods, such as Support
Vector Machines with various kernels, AdaBoost using trees as the weak learner,
logistic regression, naive bayes methods etc. We also developed a likelihood ratio
based method, K-LRT, that is able to identify the k most important features
for each patient. Our results show that with a 30% false alarm rate, we can
successfully predict 82% of the patients with heart diseases that are going to be
hospitalized in the following year. We have examined methods that have high
prediction accuracy (Adaboost with trees), as well as methods that can help
doctors identify features to help them when examining patients (K-LRT). One
could choose which one to use depending on the ultimate goal and the desirable
target for detection and false alarm rates. Our methods also produce a set of
significant features of the patients that lead to hospitalization. Most of these
features are well-known precursors of heart problems, a fact which highlights
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the validity of our models and analysis. The methods are general enough and
can easily handle new predictive variables as they become available in EHRs,
to refine and potentially improve the accuracy of our predictions.
• We showed that these accuracy rates surpass what is possible with more em-
pirical but well accepted risk metrics, such as the heart disease risk factor that
emerged out of the Framingham study. Even a more sophisticated use of the
features used in the Framingham risk factor, still leads to results inferior to
our approaches. This suggests that the entirety of a patient’s EHR is useful
in the prediction and this can only be achieved with a systematic algorithmic
approach.
• We developed a decentralized method, the cluster Primal Dual Splitting (cPDS)
method, to solve the problem of `1-regularized Support Vector Machines. We
proved that cPDS has improved o(1/k) convergence rate compared to the al-
ternatives we have considered. Our formulation has the flexibility to address a
range of problems from fully-centralized to fully-decentralized. Information pro-
cessing can happen either at the level of the patient e.g., in their smartphones
or at the level of the hospitals that process data of their own patients. cPDS
is a general framework and can be applied to any problem that has the struc-
ture of minimizing two nonsmooth terms. For the heart-related hospitalization
prediction problem, cPDS achieves AUC as high as 77%.
• We introduced a statistical procedure to identify the diabetes-related admissions
and we experimented with a number of machine learning methods that predict
hospitalizations in a target year for diabetic patients. With a 20% false alarm
rate, we can correctly predict almost 75% of the hospitalized patients.
• We developed a novel clustering and classification framework (ACC) that jointly
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discriminates between hospitalized and non-hospitalized patients and discovers
clusters of patients with key factors, different in each cluster, that lead to hos-
pitalization. The identification of the clusters has the significant advantage of
interpretability, which is crucial in the medical domain. We proved convergence
of the new algorithm and established theoretical generalization guarantees.
• If coupled with case management and preventive interventions, our methods
have the potential to prevent a significant number of hospitalizations by identi-
fying patients at greatest risk and enhancing their outpatient care before they
are hospitalized.
6.2 A Cost-Benefit Analysis
We next assess the potential financial benefits of implementing a predictive model,
such as the ones we have presented in this thesis. As an illustrative example, let us
consider the Alternating Clustering and Classification scheme for predicting diabetes-
related hospitalizations and focus on year 2012; our dataset has NH = 916 hospital-
ized and NNH = 27, 025 non-hospitalized patients that year. According to [Clancy
et al., 2011], the average cost per hospitalization due to diabetes with complications
is $9,500. Thus, assuming no spending on the non-hospitalized patients and a single
hospitalization for the hospitalized, the expected cost per patient if no prevention
measures are implemented is:
9500NH
NH +NNH
= $311.
Suppose now we elect to utilize the predictive model and operate at a point on the
ROC curve corresponding to a roughly PD = 75% detection rate and a PFA = 20%
false alarm rate (see Figure 2). We bring each patient predicted to be hospitalized to
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the clinic, at a cost of $220 for a visit according to [Clancy et al., 2011], and prescribe
an 1-year-supply of drugs at an average cost of $100. Thus, the cost of preventive
measures is $320 per patient. Notice that this overestimates the cost because for some
patients predicted to be hospitalized, the physician may decide that additional drugs
are not needed. For patients the predictive model misses, there is no action and they
would receive their normal care. Let PS the probability that prevention is effective
and averts the hospitalization. It follows that the cost per patient becomes:
9500NH(1− PD) + 320NNHPFA+ 320NHPDPS + (9500 + 320)NHPD(1− PS)
NH +NNH
.
A simple calculation implies that the above quantity is less than $311 for PS > 0.3.
Taking PS = 0.5 leads to an expected cost per patient equal to $264, resulting in
savings of $47 per patient. If such a model was used for each patient with diabetes in
the U.S. during 2002 (29.1 million), the overall savings amount to $1.3 billion for the
year! This is about 22% of the overall amount spent on preventable diabetes-related
hospitalizations each year.
6.3 Future Directions
An immediate possible extension of the cPDS framework could be the analysis of
cPDS when the graph that connects the agents is time-varying. Another possible
direction is based on the observation that IncrSub is very fast. IncrSub however
can only be a decentralized method, when the network follows a ring structure. We
would like to consider the possibility of combining cPDS and IncrSub with the goal
of generating a distributed method that is as general as cPDS and as fast as IncrSub.
Another interesting extension of this work is to move from predictive analytics,
which addresses the question of what is likely to happen, to prescriptive analytics,
which also specifies the actions that are necessary to be taken in order achieve the
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predicted outcomes.
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